Document:

Exhibit 10.19

 

Final
Version; as amended

January
7, 2020

 

2017
BOWLMOR AMF CORP. STOCK INCENTIVE PLAN

 

ARTICLE
1

Purpose

 

Bowlmor
AMF Corp., a Delaware corporation (the “Company”), hereby establishes the 2017 Bowlmor AMF Corp. Stock Incentive Plan
(the “Plan”), effective as of September 29, 2017 (the “Effective Date”). The purpose of the Plan
is to advance the interests of the Company and its stockholders by providing a means by which the Company and its Subsidiaries can attract,
retain and motivate selected directors, officers, other employees and consultants and provide such personnel with an opportunity to participate
in the increased value of the Company, which their effort, initiative and skill have helped produce.

 

ARTICLE
2

Definitions

 

As
used in the Plan, the following terms shall have the meanings set forth below:

 

“Affiliate”
means, with respect to any Person, any other Person directly or indirectly controlling, controlled by or under common control with such
Person. For the purpose of this definition, the term “control” (including, with correlative meanings, the terms “controlling,”
“controlled by” and “under common control with”), as used with respect to any Person, means the possession, directly
or indirectly, of the power to direct or cause the direction of the management and policies of such Person, whether through the ownership
of voting securities, by contract or otherwise.

 

“Atairos
Entities” means Atairos Group, Inc., a Cayman Islands exempted company, Atairos Partners, L.P., Atairos Management, L.P. and
A-B Parent LLC, a Delaware limited liability company.

 

“Award”
means any grant of an Option or Other Share-Based Award under the Plan.

 

“Award
Agreement” means any written agreement, contract or other instrument or document evidencing any Award, which may, but need
not (as determined by the Committee), be required to be executed or acknowledged by a Participant as a condition precedent to receiving
an Award or the benefits under an Award.

 

“Beneficial
owner” or “beneficially own” has the meaning given to such term in Rule 13d-3 under the Exchange Act.

 

     

     

    

 

“Board”
means the board of directors of the Company.

 

“Cause”
has the definition set forth in a Participant’s employment agreement with the Company or any of its Subsidiaries or, in the absence
of such a definition, means the Participant’s: (i) conviction of a felony or any crime involving dishonesty or theft; (ii) fraudulent,
unlawful or grossly negligent conduct in connection with the Participant’s employment duties or responsibilities; (iii) willful
misconduct; (iv) contravention of specific lawful directions from the Board related to a material duty or responsibility; (v) material
breach of the obligations of any agreement with the Company; (vi) acts of dishonesty resulting or intending to result in personal gain
or enrichment at the expense of the Company or its Affiliates; (vii) material failure to comply with a material written policy of the
Company; or (viii) material act or omission which is, or could reasonably be expected to become, materially injurious to the reputation
or business of the Company or its Affiliates.

 

“Change
in Control” has the meaning set forth in the Stockholders’ Agreement.

 

“Code”
means the Internal Revenue Code of 1986, as amended, and applicable rules and regulations thereunder.

 

“Committee”
means a committee of two or more members of the Board designated by the Board to administer the Plan, or if no such committee has been
designated, the Board, in each case subject to recusal as appropriate.

 

“Common
Shares” means shares of the common stock of the Company and any other security into which such common stock may hereafter be
converted or changed.

 

“Company
Group” means the Company, its Subsidiaries, and any of their Affiliates, including, for the avoidance of doubt, the Atairos
Entities and their portfolio companies.

 

“Disability”
means any medically determinable physical or mental impairment resulting in the Participant’s inability to substantially perform
the duties of the Participant’s role with the Company, where such impairment is likely to result in death or can be expected to
last for a continuous period of not less than 12 months, as determined reasonably and in good faith by the Committee.

 

“Eligible
Individual” has the meaning set forth in Article 5.

 

    2

     

    

 

“Encumbrance”
means any lien, security interest, pledge, claim, option, right of first refusal, marital right or other encumbrance with respect to
any Common Share issued in respect of any Award.

 

“Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the applicable rules and regulations thereunder.

 

“Exercise
Price” means the price at which a Common Share may be purchased by a Participant pursuant to an Option, as set forth in the
relevant Grant Notice and/or Award Agreement.

 

“Fair
Market Value” means, with respect to a Common Share as of any date of determination, the fair market value as determined in
good faith by the Board.

 

“Grant
Notice” means any notice of the Award of Stock Options that is issued and accompanied by any Award Agreement which may, but
need not (as determined by the Committee), be required to be executed or acknowledged by a Participant as a condition precedent to receiving
an Award or the benefits under an Award.

 

“Incentive
Stock Option” means an Option that is intended to meet the requirements of Section 422 of the Code.

 

“Involuntary
Transfer” means a transfer of a Participant’s Award or any Common Share issued in respect of any Award by operation of
law including, without limitation, as a result of (i) a sale or other disposition by a trustee or debtor in possession appointed or retained
in a bankruptcy case, (ii) a sale at any creditors’ or judicial sale or (iii) a transfer arising out of a divorce or separation
proceeding.

 

“Nonqualified
Stock Option” means an Option that is not intended to meet the requirements of Section 422 of the Code.

 

“Option”
means an option to purchase Common Shares granted to an Eligible Individual under the Plan.

 

“Other
Share-Based Award” means any award granted under the Plan denominated in or based on Common Shares or the value or change in
value of Common Shares or the dividends paid on Common Shares.

 

    3

     

    

 

“Participant”
means an Eligible Individual who receives an Award under the Plan.

 

“Permitted
Transferee” has the meaning set forth in the Stockholders’ Agreement.

 

“Person”
means an individual, corporation, limited liability company, partnership, association, trust or other entity or organization, including
a government or political subdivision or an agency or instrumentality thereof.

 

“Plan”
has the meaning set forth in Article 1.

 

“Section
409A” has the meaning assigned to it in Article 14. “Securities Act” means the Securities Act of 1933, as
amended, and the applicable rules and regulations thereunder.

 

“Stockholder”
has the meaning set forth in the Stockholders’ Agreement. “Stockholders’ Agreement” means that certain
Stockholders’ Agreement by and among (i) the Company, (ii) A-B Parent LLC, a Delaware limited liability company, (iii) Cobalt Recreation
LLC, a Delaware limited liability company, (iv) Thomas F. Shannon and (v) Atairos Group, Inc., a Cayman Islands exempted company, dated
as of June 6, 2017, as amended from time to time.

 

“Subsidiary”
means with respect to any Person, any entity of which securities or other ownership interests having ordinary voting power to elect a
majority of the board of directors or other persons performing similar functions are at the time directly or indirectly owned by such
Person.

 

“Substitute
Award” means an Award granted pursuant to Article 5 in assumption of, or as an alternative to or replacement of, an outstanding
award previously granted by a business or entity all or a portion of which is acquired by the Company or any of its Affiliates or Subsidiaries,
or with which the Company or any of its Affiliates or Subsidiaries combines.

 

“Unvested
Award” means, as of any date, any Award (or any portion thereof) which by its terms has not yet vested and become exercisable
as of such date.

 

“Vested
Award” means, as of any date, any Award (or any portion thereof) which by its terms has vested and become exercisable as of
such date.

 

    4

     

    

 

ARTICLE
3

Administration

 

Section
3.01. Committee. The Plan shall be administered by the Committee.

 

Section
3.02. Authority of the Committee. Subject to the provisions of the Plan, the Committee shall have the authority, in its discretion
and on behalf of the Company:

 

(a)
to select from among the Eligible Individuals those persons who shall receive Awards, to determine the time or times of receipt, to determine
the types of Awards and the number of Common Shares covered by the Awards, to establish the terms, conditions, performance criteria,
restrictions and other aspects of the Awards and the provisions of the applicable Award Agreement and to modify, amend, cancel or suspend
Awards;

 

(b)
to interpret the Plan;

 

(c)
to prescribe, amend and rescind any rules and regulations relating to the Plan;

 

(d)
to determine whether, to what extent and under what circumstances Awards may be settled in cash, Common Shares, other Awards or other
property, including without limitation the authority to settle Awards in cash or property upon a Change in Control or other similar corporate
transaction;

 

(e)
to determine whether, to what extent and under what circumstances cash, Common Shares, other Awards, other property and any other amounts
payable with respect to an Award shall or may be deferred either automatically or at the election of the Participant or of the Committee;

 

(f)
to cancel and regrant, accelerate vesting or otherwise adjust the Exercise Price of an Award previously granted under the Plan; and

 

(g)
to make all other determinations and findings, including factual findings, deemed necessary or advisable for the administration of the
Plan.

 

Section
3.03. Committee Discretion. In exercising its authority, the Committee shall have the broadest possible discretion. Unless otherwise
expressly provided in the Plan, all designations, determinations, interpretations and other decisions made in good faith by the Committee
under or with respect to the Plan, any Award or Award Agreement shall be final, binding and conclusive on all persons.

 

Section
3.04. Committee Delegation. To the extent permitted by applicable law, the Committee may delegate its authority, or specified
items thereof, to one or more designated officers of the Company or other committees of the Board.

 

    5

     

    

 

ARTICLE
4

Shares
Subject to the Plan

 

Section
4.01. General Limitation.

 

(a)
Subject to Section 4.02 below, the maximum number of Common Shares that may be issued or used for reference purposes under the Plan is
2,036,158 Common Shares.

 

(b)
To the extent any Common Shares covered by an Award, other than a Substitute Award, are not issued because the Award is forfeited, canceled
or expires without being exercised, such Common Shares shall not be deemed to have been issued for purposes of determining the maximum
number of Common Shares available for issuance under the Plan.

 

(c)
Notwithstanding anything to the contrary in Section 4.01(b) above, Commons Shares subject to an Award shall not again be available for
issuance under the Plan if such Common Shares are (i) Common Shares tendered to or withheld by the Company (by either actual delivery
or by attestation) to satisfy payment of the Exercise Price of any Option or any Other Share-Based Award granted under the Plan, other
than a Substitute Award, or (ii) not delivered because the Award is settled in cash or are Common Shares withheld to satisfy applicable
tax obligations or other obligations arising from an Option or other Award.

 

(d)
Any Common Shares underlying a Substitute Award shall not be deemed to have been issued for purposes of determining the maximum number
of Common Shares remaining available for issuance under the Plan.

 

Section
4.02. Adjustments. In the event that any corporate transaction or distribution (including, without limitation, any stock split,
stock dividend, extraordinary cash dividend, recapitalization, reorganization, merger, consolidation, split up, spin off, repurchase,
combination or exchange of Common Shares or other securities of the Company, sale or transfer of all or substantially all of the Company’s
assets or business or any other transaction or event that would be considered an “equity restructuring” within the meaning
of FASB ASC Topic 718, but not including ordinary cash dividends) affects the Common Shares such that an adjustment is appropriate in
order to prevent dilution or enlargement of the benefits or potential benefits intended to be made available under the Plan, then (a)
the Committee shall, in such manner as it may deem equitable, adjust any or all of (i) the number of Common Shares or other securities
of the Company (or number and kind of other securities or property) with respect to which Awards may be granted under Section 4.01; (ii)
the number of Common Shares or other securities of the Company (or number and kind of other securities and property) subject to outstanding
Awards; and (iii) the Exercise Price or other terms and conditions of any Award or, (b) if deemed appropriate, the Committee may make
provision for a cash payment to the holder of an outstanding Award in full satisfaction of such Award.

 

    6

     

    

 

Section
4.03. Other Provisions. The grant of any Award may also be subject to such other provisions as the Committee deems appropriate
(whether or not applicable to any Award granted to any other Participant).

 

ARTICLE
5

Eligibility
and Participation

 

Key
employees and other service providers of the Company or any of its Subsidiaries who are expected to be important to the ongoing business
of the Company and any of its Subsidiaries shall be eligible to participate in and receive Awards under the Plan, which individuals will
be selected by the Committee (each, an “Eligible Individual”). Awards may be granted on conditions specified by the
Committee.

 

ARTICLE
6

Awards

 

Section
6.01. Options.

 

(a)
General. The Committee is authorized to grant Options under the Plan, which shall be evidenced by an Award Agreement and shall
contain terms and conditions not inconsistent with the following limitations and conditions.

 

(b) Exercise
Price. Each Grant Notice and/or Award Agreement shall set forth the Exercise Price of each Option, which shall be established by
the Committee at the time the Option is granted. Unless otherwise determined by the Committee with respect to an Option intended to
be subject to Section 409A, the Exercise Price shall not be less than the Fair Market Value of a Common Share on the date of grant
of the Option (which shall not be less than the “fair market value” of a Common Share within the meaning of Section
409A).

 

(c)
Number of Common Shares. Each Grant Notice and/or Award Agreement shall specify the number of Common Shares that are subject to
the Award.

 

    7

     

    

 

(d)
Vesting. The vesting schedule for each grant of Options shall be set forth in the applicable Grant Notice and/or Award Agreement,
including the treatment of outstanding Options upon a Participant’s termination of employment or service.

 

(e)
Limitations on Exercisability. An Option shall be exercisable only in accordance with the terms and conditions and during such
periods as may be established by the Committee in the Award Agreement, or otherwise in accordance with the Plan and the Award Agreement.
The Committee may, in its discretion, provide that such an Option may be exercised in whole or in part, in installments, cumulative or
otherwise, for any period of time specified by the Committee or based on performance or other criteria established by the Committee.

 

(f)
Payment. No Common Shares shall be delivered pursuant to any exercise of an Option until payment in full of the Exercise Price,
or adequate provision therefor (in the discretion of the Committee), is received by the Company. Such payment may be made in cash or
solely to the extent permitted by the applicable Award Agreement or otherwise permitted by the Committee, in part or in whole (i) in
Common Shares owned by the Participant or in Common Shares which may be received by the Participant upon exercise of the Option (in each
case, the value of such Common Shares shall be their Fair Market Value on the date of exercise); (ii) in other property acceptable to
the Committee; or (iii) by any combination thereof.

 

(g)
Term of Options. An Option and all rights and obligations thereunder shall expire on the date to be determined by the Committee
and set forth in the applicable Award Agreement.

 

(h)
Incentive Stock Options. The terms of any Incentive Stock Option granted under this Plan shall comply in all respects with the
provisions of Section 422 of the Code. Subject to adjustment under Section 4.02, the maximum number of Common Shares that may be issued
under Incentive Stock Options under the Plan is 200,000.

 

    8

     

    

 

Section
6.02. Other Share-Based Awards. The Committee is authorized to grant unrestricted Common Shares or Other Share-Based Awards under
the Plan to Participants, alone or in tandem with other Awards, in such amounts and subject to such terms and conditions, including vesting
schedules or other criteria, including performance criteria, as the Committee will from time to time in its sole discretion determine.

 

Section
6.03. Settlement of Awards. Common Shares delivered pursuant to the exercise of an Option or the exercise or vesting and settlement
of Other Share-Based Awards shall be subject to any such additional conditions (other than vesting conditions), restrictions and contingencies
as the Committee may establish pursuant to the Plan and the applicable Award Agreement, in addition to the conditions set forth herein.

 

Section
6.04. Stockholders’ Agreement. Each Participant who is granted any Award shall, as a condition to the grant of such Award,
execute an agreement pursuant to which he or she shall become a party to the Stockholders’ Agreement. The Stockholders’ Agreement
is hereby incorporated by reference herein in its entirety, and each Participant and all of his or her Awards and Common Shares held
pursuant to the exercise or settlement of his or her Awards shall be subject to the terms of the Stockholders’ Agreement, including,
without limitation, those

terms
relating to the Company’s call rights, tag-along rights, drag-along rights and other rights and obligations of the Company and
its stockholders relating to the Awards and underlying Common Shares set forth therein.

 

Section
6.05. Other Provisions. The grant of any Award may also be subject to such other provisions as the Committee deems appropriate
(whether or not applicable to any Award granted to any other Participant), including the treatment of Awards and Common Shares upon the
occurrence of any corporate transaction or distribution involving the Company, including any merger, reorganization, recapitalization
or other similar corporate event.

 

    9

     

    

 

ARTICLE
7

Change
in Control

  

Section
7.01 Committee Actions on a Change in Control. In the event of a Change in Control, the Committee will have full discretion, subject
to any applicable regulatory approvals, and subject to the terms of any Award Agreement, to take whatever actions that it deems necessary
or appropriate with respect to outstanding Awards, including: (a) to provide for full or partial accelerated vesting of any Award or
portion thereof, either immediately prior to such Change in Control or on such terms and conditions following the Change in Control as
the Committee may determine in its sole discretion; (b) to provide for the assumption of an Award (or portions thereof) or the issuance
of Substitute Awards with similar rights and features of the surviving or acquiring Company (subject to Section 409A, where applicable);
(c) to provide for the cash-out and cancelation of any Vested Award (or portion thereof) immediately prior to such Change in Control,
which cash-out may (subject to Section 409A, where applicable) be subject to any escrow, earn-out or other contingent or deferred payment
arrangement that is contemplated by such Change in Control; (d) subject to any special vesting provisions of the applicable Award Agreement,
to cancel, without consideration, any Unvested Award and any other Award that is not otherwise exercised on or prior to any Change in
Control; provided that, for the avoidance of doubt, if the Award has an Exercise Price that exceeds the Fair Market Value of the
Common Shares underlying the Award, the Award may be canceled for no consideration; or (e) subject to any express provisions of the applicable
Award Agreement, to take any other actions as the Committee deems necessary or advisable in connection with such Change in Control, including
taking different actions with respect to different Participants under the Plan, different Awards under the Plan and different portions
of Awards granted under the Plan.

 

ARTICLE
8

Tax
Withholding

 

The
delivery of Common Shares or other benefits under any Award shall be subject to satisfaction of all applicable withholding requirements.
The Committee, in its sole discretion and subject to such requirements as it may prescribe, may permit such withholding or other tax
obligations to be satisfied through any combination of the following: (a) cash payment by the Participant; (b) payroll withholding of
the Participant’s salary, wages or other compensation; (c) surrender of Common Shares which the Participant already owns (either
by actual surrender or attestation); or (d) surrender of Common Shares or other benefits to which the Participant is otherwise entitled
(e.g., upon exercise of an Option) under the terms of the Plan.

 

    10

     

    

 

ARTICLE
9

Transferability

 

Section
9.01. Transferability of Awards. Except as otherwise expressly permitted by the Committee, no Award may be assigned, alienated,
pledged, attached, sold or otherwise transferred or encumbered by a Participant other than by will or by the laws of descent and distribution.
An Option (or Other Share- Based Award subject to exercise) may be exercised during the lifetime of the Participant only by him or her
or by his or her legal representative. Any attempt to Transfer any such Award not in accordance with the provisions of Section 6.04 shall
be void and immediately cancelled, and no Award shall in any manner be liable for or subject to the debts, contracts, liabilities, engagements
or torts of any person who shall be entitled to such Award, nor shall it be subject to attachment or legal process for or against such
person.

 

Section
9.02. Transferability of Common Shares. Prior to termination of the Stockholders’ Agreement, except as otherwise expressly
provided in the Stockholders’ Agreement, Common Shares issued in respect of an Award may not be anticipated, assigned, attached,
garnished, optioned, transferred or made subject to any creditor’s process, whether voluntarily, involuntarily or by operation
of law.

 

Section
9.03. Continuation of Terms. To the extent any transfer of any Award or of any Common Shares issued in respect of an Award is
permitted pursuant to Section 9.01 or Section 9.02, (a) any transferee of any such Award or Common Share shall, by virtue of and as a
condition to such transfer, agree to be bound by the terms of the Plan, the applicable Award Agreement and the Stockholders’ Agreement
and (b) the provisions of the Plan and the Award Agreement with respect to such Award or Common Shares will continue to apply as though
the Award or Common Shares were still held by the applicable Participant.

 

ARTICLE
10

Limitation
on Implied Rights

 

Section
10.01. Property Rights. Neither a Participant nor any other Person shall, by reason of participation in the Plan, acquire any
right in or title to any assets, funds or property of any member of the Company Group whatsoever including without limitation, any specific
funds, assets or other property which any member of the Company Group, in its or their sole discretion, may set aside in anticipation
of a liability under the Plan. Subject to the terms of the Plan, a Participant shall have only a contractual right to the Common Shares
or amounts, if any, payable under the Plan, unsecured by any assets of any member of the Company Group, and nothing contained in the
Plan shall constitute a representation or guarantee that the assets of any member of the Company Group shall be sufficient to pay any
benefits to any Person.

 

    11

     

    

 

Section
10.02. Employment Rights. Nothing in this Plan nor in any Award Agreement shall confer upon any Participant any promise or commitment
by any member of the Company Group regarding employment, employment positions, work assignments, compensation or any other term or condition
of employment or affiliation.

 

Section
10.03. No Implied Rights or Obligations. The Company, in establishing and maintaining this Plan as a voluntary and unilateral
undertaking, expressly disavows the creation of any rights in Participants or others claiming entitlement under the Plan or any obligations
on the part of any member of the Company Group, or the Committee, except as expressly provided herein. No Award shall be deemed to be
salary or compensation for the purposes of computing benefits under any employee benefit, severance, pension or retirement plan of the
Company or any of its Subsidiaries, unless the Committee shall determine otherwise, applicable local law provides otherwise or the terms
of such plan specifically include such compensation.

 

Section
10.04. No Trust or Fund Created. Neither the Plan nor any Award shall create or be construed to create a trust or separate fund
of any kind or a fiduciary relationship between any member of the Company Group and a Participant or any other Person. To the extent
that any Person acquires a right to receive payments from any member of the Company Group pursuant to an Award, such right shall be no
greater than the right of any unsecured general creditor of the Company.

 

Section
10.05. Rights as a Stockholder. No Participant or holder of any Award shall have any rights as a Stockholder with respect to any
Common Shares underlying such Award until the Award has been exercised or settled, and the Participant or holder has been issued Common
Shares in accordance with the terms of the Plan.

 

Section
10.06. Additional Conditions of Awards. The Committee may specify in an Award Agreement that the Participant’s rights, payments
and benefits with respect to an Award will be subject to reduction, cancelation, forfeiture or recoupment upon the occurrence of certain
specified events, in addition to any otherwise applicable vesting or performance conditions of an Award. Such events may include a termination
of the Participant’s employment or service with the Company or any of its Subsidiaries, a violation of material policies, breach
of noncompetition, confidentiality or other restrictive covenants that may apply to the Participant or other conduct by the Participant
that is detrimental to the business or reputation of any member of the Company Group.

 

    12

     

    

 

Section
10.07. No Fractional Common Shares. No fractional Common Shares will be issued or delivered pursuant to the Plan or any Award,
and the Committee will determine whether cash or other securities will be paid or transferred in lieu of any fractional Common Shares,
or whether such fractional Common Shares or any rights thereto will be canceled, terminated or otherwise eliminated.

 

Section
10.08. Variations by Jurisdiction. Awards may be granted to Participants in different legal jurisdictions on such terms and conditions
as may, in the judgment of the Committee, be necessary or desirable to recognize differences in local law, tax policy or custom. The
Committee also may impose conditions on the exercise or vesting of Awards in order to minimize the Company’s obligation with respect
to tax equalization for Participants on assignments outside their home country.

 

Section
10.09. Data Protection. By participating in the Plan, the Participant consents to the holding and processing of personal information
provided by the Participant to the Company, its Subsidiaries, any of their Affiliates (including, for the avoidance of doubt, the Atairos
Entities), trustee or third-party service provider, for all purposes relating to the operation of the Plan. These include:

 

(a)
administering and maintaining Participant records;

 

(b)
providing information to the Company, its Subsidiaries, any of their Affiliates (including, for the avoidance of doubt, the Atairos Entities),
trustees of any employee benefit trust, registrars, brokers or third-party administrators of the Plan;

 

(c)
providing information to future purchasers or other transaction counterparties of the Company, its Subsidiaries, and any of their Affiliates
(including, for the avoidance of doubt, the Atairos Entities), or the business in which the Participant works; and

 

    13

     

    

 

(d)
transferring information about the Participant to any country or territory that may not provide the same protection for the information
as the Participant’s home country.

 

Section
10.10. Listing and Other Conditions.

 

(a)
Unless otherwise determined by the Committee, if at any time the Common Shares are listed on a national securities exchange or system
sponsored by a national securities association, the issuance of any Common Shares pursuant to an Award shall be conditioned upon such
shares being listed on such exchange or system. The Company shall have no obligation to issue such shares unless and until such shares
are so listed, and the right to exercise any Award with respect to such shares shall be suspended until such listing has been effected.

 

(b)
If at any time counsel to the Company shall be of the opinion that any sale or delivery of Common Shares pursuant to an Award is or may
in the circumstances be unlawful or result in the imposition of excise taxes on the Company under the statutes, rules or regulations
of any applicable jurisdiction, the Company shall have no obligation to make such sale or delivery, or to make any application or to
effect or to maintain any qualification or registration under the Securities Act or otherwise with respect to any Common Shares or Awards,
and the right to exercise any Award shall be suspended until, in the opinion of said counsel, such sale or delivery shall be lawful and
will not result in the imposition of excise taxes on the Company.

 

(c)
Upon termination of any period of suspension under this Section 10.10, an Award affected by such suspension that shall not then have
expired or terminated shall be reinstated as to all Common Shares available before such suspension and as to Common Shares that would
otherwise have become available during the period of such suspension, but no such suspension shall extend the term of any Award.

 

(d)
A Participant shall be required to supply the Company with any certificates, representations and information that the Company requests
and otherwise cooperate with the Company in obtaining any listing, registration, qualification, exemption, consent or approval the Company
deems necessary or appropriate.

 

    14

     

    

 

ARTICLE
11

Amendments,
Suspensions or Termination of the Plan

 

Section
11.01. Amendment and Termination of the Plan. The Board may at any time amend, suspend or terminate the Plan from time to time,
provided, however, that no such amendment, alteration, suspension, discontinuation or termination shall be made without approval
by the stockholders of the Company if such approval is necessary to comply with any tax or regulatory requirement for which or with which
the Board deems it necessary or desirable to qualify or comply; provided that any such amendment, alteration, suspension, discontinuation
or termination that would materially adversely impair the rights of any Participant or any holder of any Award theretofore granted will
not, to that extent, be effective without the consent of the affected Participant or holder, except that the Stockholders’ Agreement
may be amended without the consent of a Participant in accordance with the terms thereof.

 

Section
11.02. Amendment of Award Agreements. The Committee may waive any conditions or rights under, amend any terms of, or alter, suspend,
discontinue, cancel or terminate, any Award theretofore granted or the associated Award Agreement, prospectively or retroactively; provided
that any such waiver, amendment, alteration, suspension, discontinuance, cancelation or termination that would materially adversely
impair the rights of any Participant or any holder of any Award theretofore granted will not, to that extent, be effective without the
consent of the affected Participant or holder, except that the Stockholders’ Agreement may be amended without the consent of a
Participant in accordance with the terms thereof.

 

Section
11.03. Corrections. The Committee may correct any defect, supply any omission or reconcile any inconsistency in the Plan or any
Award in the manner and to the extent that it shall deem desirable to carry the Plan into effect.

 

Section
11.04. Severability of Provisions. If any provision of the Plan shall be held invalid or unenforceable, such invalidity or unenforceability
shall not affect any other provisions hereof, and the Plan shall be construed and enforced as if such provisions had not been included;
provided, however, that if the Company’s call rights set forth in the Stockholders’ Agreement or other agreement shall
be held invalid or unenforceable, the Awards granted under the Plan shall be cancelled and terminated.

 

    15

     

    

 

ARTICLE
12

Termination

 

The
Plan shall continue in effect until July 3, 2027, unless earlier terminated by the Board pursuant to Article 11; provided that,
following any termination of the Plan, the terms of the Plan shall continue to apply to any Award for as long as the Award remains outstanding
pursuant to its terms.

 

ARTICLE
13

Governing
Law; Waiver of Jury Trial

 

The
validity, construction and effect of the Plan, the Award Agreements and any rules, regulations or procedures relating thereto shall be
governed by, and construed in accordance with, the laws of the State of Delaware, without regard to the conflicts of laws rules of such
state. Participants acknowledge and agree that any controversy which may arise under or relate to the Plan or an Award Agreement is likely
to involve complicated and difficult issues, and the Company and each Participant will agree to irrevocably waive any and all rights
to trial by jury in any legal proceeding arising out of or relating to the Plan or an Award Agreement, or the transactions and matters
contemplated hereby or thereby.

 

ARTICLE
14

Section
409A of the Code

 

The
Plan is intended to comply with the requirements of Section 409A of the Code and the regulations and guidance thereunder (respectively,
“Section 409A”), the provisions of the Plan shall be interpreted in a manner that satisfies such requirements, and
the Plan shall be operated accordingly. If any provision of the Plan would otherwise frustrate or conflict with this intent, the provision
shall be interpreted and deemed amended so as to avoid this conflict. If an operational failure occurs with respect to the requirements
of Section 409A, any affected Participant shall fully cooperate with the Company to correct the failure, to the extent possible, in accordance
with any correction procedure established by the Internal Revenue Service. No provision of the Plan shall be interpreted to transfer
any liability for a failure to comply with Section 409A from a Participant or any other Person to the Company.

 

Notwithstanding
any provision of the Plan or any Award Agreement, if at the time of termination of a Participant’s employment or service with the
Company or any of its Subsidiaries he or she is a “specified employee” (as defined in Section 409A) and any payments upon
such termination under the Plan or such Award Agreement are treated as deferred compensation subject to Section 409A, he or she shall
not be entitled to such payments until the earlier of (a) the date that is six months after such termination or (b) any earlier date
that does not result in any additional tax or interest to such Participant under Section 409A. For purposes of Section 409A, any payment
or settlement of an Award made under the Plan shall be designated as a “separate payment” within the meaning of Section 409A.

 

 

16Exhibit
10.24

 

EXECUTION
COPY

 

EMPLOYMENT
AGREEMENT

 

THIS
EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into this 6th day of June, 2017, by and between Bowlmor
AMF Corp., a Delaware corporation (the “Company”), and Thomas F. Shannon (the “Executive”).

 

THE
PARTIES ENTER THIS AGREEMENT on the basis of the following facts, understandings and intentions:

 

A.
This Agreement shall govern the employment relationship between the Executive, on the one hand, and the Company, on the other hand,
from and after the date of the closing (the “Effective Date”) of that certain Agreement and Plan of Merger by and
among A-B Parent LLC, a Delaware limited liability company; A-B Merger Sub I Inc., a Delaware corporation; A-B Merger Sub II LLC, a Delaware
limited liability company; the Company; Kingpin Intermediate Holdings LLC, a Delaware limited liability company; and Cerberus Series
Four Holdings, LLC, solely in its capacity as Stockholder Representative, dated as of June 6, 2017 (the “Merger Agreement”).

 

B.
From and after the Effective Date, this Agreement supersedes and negates all previous agreements with respect to the employment relationship
between the Executive, on the one hand, and the Company, on the other hand.

 

C.
The Executive desires to be employed by the Company on the terms and conditions set forth in this Agreement.

 

NOW,
THEREFORE, in consideration of the above recitals incorporated herein and the mutual covenants and promises contained herein and
other good and valuable consideration, the receipt and sufficiency of which are hereby expressly acknowledged, the parties agree as follows:

 

1.
Retention and Duties.

 

1.1
Retention. The Company hereby hires, engages and employs the Executive for the Period of Employment (as such term is defined
in Section 2) on the terms and conditions expressly set forth in this Agreement. The Executive does hereby accept and agree to such hiring,
engagement and employment, on the terms and conditions expressly set forth in this Agreement.

 

1.2 Duties.
During the Period of Employment, the Executive shall serve the Company as its President and Chief Executive Officer and shall have
the powers, authorities, duties and obligations of management usually vested in the office of the President and Chief Executive Officer
of a company of a similar size and similar nature of the Company, and such other powers, authorities, duties and obligations commensurate
with such position as the Company’s Board of Directors (the “Board”) may reasonably assign from time to time.
During the Period of Employment, the Executive shall report solely to the Board. The Executive shall be elected to the Board, shall initially
serve as the Chairman of the Board, and shall serve during the Period of Employment as a member of the Board, without any additional
compensation therefor, subject to the terms of the Stockholders’ Agreement by and among (i) the Company, (ii) A-B Parent LLC, a
Delaware limited liability company, (iii) Cobalt Recreation LLC, a Delaware limited liability company, (iv) the Executive and (v) Atairos
Group, Inc., a Cayman Islands exempted company, dated as of June 6, 2017 (the “Stockholders’ Agreement”).

 

     

     

    

 

1.3
No Other Employment; Minimum Time Commitment. During the Period of Employment, the Executive shall devote substantially all
of his business time, energy and skill to the performance of the Executive’s duties for the Company, and shall hold no other employment.
During the Period of Employment, the Executive may serve on no more than three (3) for-profit boards of directors (or similar body) of
other business entities at any given time, unless otherwise permitted by the Board. The Executive’s service on any additional for-profit
boards of directors (or similar body) of other business entities is subject to the prior written approval of the Board, which approval
shall not unreasonably be withheld or delayed. Nothing herein shall preclude the Executive from (i) engaging in a reasonable level of
charitable activities and community affairs, including serving on non-profit boards of directors or the equivalent, and (ii) managing
his personal and family investments and affairs, provided that such activities do not materially interfere with the effective discharge
of his duties and responsibilities to the Company. The Company shall have the right (upon written notice and subject to the Executive
fulfilling his fiduciary obligations as a member of the applicable board or body) to require the Executive to resign from any board or
similar body (including, without limitation, any association, corporate, civic or charitable board or similar body) on which the Executive
may then serve (or reduce his involvement) if the Board reasonably determines in good faith that any business related to such service
is then in competition with any business of the Company or any Subsidiaries (as such term is defined in Exhibit A). In the event
any such resignation (or reduction in involvement) is required of the Executive, the Executive shall so resign (or reduce his involvement)
as soon as he can practicably do so without violating any fiduciary duty he may have to such other organization.

 

1.4
No Breach of Contract. The Executive hereby represents to the Company that the execution and delivery of this Agreement by
the Executive after execution and delivery by the Company, and the performance by the Executive of the Executive’s duties hereunder,
do not and shall not constitute a breach of, conflict with, or otherwise contravene or cause a default under, the terms of any other
agreement or policy to which the Executive is a party or otherwise bound or any judgment, order or decree to which the Executive is subject.

 

1.5
Location. The Executive’s principal place of employment shall be at a location to be reasonably determined by the parties
in the greater Broward County, Florida, area. The Executive acknowledges and agrees to travel as appropriate in performing the Executive’s
duties for the Company, including travel to the Company’s headquarters as necessary.

 

2.
Period of Employment.  The “Period of Employment” shall be a period commencing on the Effective Date and
ending at the close of business on the sixth (6th) anniversary of the Effective Date (such date, the “Expiration Date”);
provided, however, that this Agreement shall be automatically renewed, and the Period of Employment shall be automatically
extended for one (1) additional year on the Expiration Date and each anniversary of the Expiration Date thereafter, unless the Executive
gives notice to the Company, or the Company gives notice to the Executive, at least six (6) months prior to the expiration of the Period
of Employment (including any renewal thereof) of such party’s desire to terminate the Period of Employment (such notice to be delivered
in accordance with Section 17). The term “Period of Employment” shall include any extension thereof pursuant to the preceding
sentence. Provision of notice that the Period of Employment shall not be extended or further extended, as the case may be, shall not
constitute a breach of this Agreement and shall not constitute “Good Reason” for purposes of this Agreement. Notwithstanding
the foregoing, the Period of Employment is subject to earlier termination as provided below in this Agreement.

 

    2

     

    

 

3.
Compensation.

 

3.1
Base Salary. During the Period of Employment, and for Executive’s services to the Company, the Company shall pay the
Executive a base salary (the “Base Salary”), which shall be paid in accordance with the Company’s regular payroll
practices in effect from time to time, but not less frequently than in semi-monthly installments. The Executive’s initial Base
Salary shall be at an annualized rate of $1,141,865.40. On each anniversary of the Effective Date (or, if the Effective Date falls on
a day other than the first day of the month, the first day of the month following each anniversary of the Effective Date), the Executive’s
rate of Base Salary shall be increased from the rate then in effect by an amount equal to the greater of (i) the consumer price index
for the New York-Northern New Jersey-Long Island area as reported by the Bureau of Labor Statistics of the United States Department of
Labor or (ii) two percent (2%).

 

3.2
Incentive Bonus. The Executive shall be eligible to receive an annual incentive bonus based on the terms and conditions set
forth in Exhibit B (the “Annual Incentive Bonus”).

 

3.3
Employee Incentive Plan. The Company shall adopt on or prior to the Effective Date the equity incentive plan of the Company
(the “Equity Incentive Plan”), the terms of which are set forth in Exhibit E. On the Effective Date, the Company
shall grant Executive an award of options under such Equity Incentive Plan equal to 75% of 75% of the Initial Options (as defined in
Exhibit E), the terms of which are set forth in Exhibit E.

 

4.
Benefits.

 

4.1
Retirement, Welfare and Fringe Benefits. During the Period of Employment, the Executive shall be entitled to participate in
all employee pension and welfare benefit plans and programs, and fringe and any other employee benefit plans and programs, made available
by the Company to its executive officers generally, in accordance with the generally applicable eligibility and participation provisions
of such plans at a level commensurate with his position, and as such plans or programs may be in effect from time to time.

 

4.2
Reimbursement of Business Expenses. The Company shall reimburse the Executive for all reasonable business expenses the Executive
incurs during the Period of Employment in connection with carrying out the Executive’s duties for the Company under this Agreement,
subject to the Company’s expense reimbursement policies in effect from time to time. In addition, the Company shall reimburse the
Executive for or pay the reasonable legal fees incurred by the Executive relating to the negotiation and preparation of this Agreement
(and any related plan or agreement).

 

    3

     

    

 

4.3
Vacation and Other Leave. During the Period of Employment, the Executive shall accrue and be entitled to take paid vacation
at a rate of four (4) weeks per year (or such greater vacation benefits as may be provided under the vacation policies applicable to
the Company’s senior executives in effect from time to time), subject to the Company’s policies regarding vacation accruals,
including any policy which may limit vacation accruals and/or limit the amount of accrued but unused vacation to carry over from year
to year. The Executive shall also be entitled to all other holiday and leave pay generally available to other executives of the Company.

 

4.4
Automobile Allowance. During the Period of Employment, the Company shall provide the Executive with an automobile allowance
of Three Thousand Dollars ($3,000) (“Automobile Allowance”) per month as full payment or reimbursement to Executive
for automobile-related expenses, with such monthly amount to be paid to the Executive not later than three (3) business days prior to
the beginning of the applicable month.

 

5.
Termination.

 

5.1
Termination by the Company. The Executive’s employment by the Company, and the Period of Employment, may be terminated
at any time by the Company: (a) with Cause (as such term is defined in Exhibit A); or (b) upon not less than thirty (30) days
prior written notice to the Executive, without Cause; or (c) in the event of the Executive’s death; or (d) in the event that it
is determined that the Executive has a Disability (as such term is defined in Exhibit A). The Company may, if it so chooses, place
Executive on paid leave of absence for any such thirty (30) day notice period referred to in clause (b) above (or any portion of such
period).

 

5.2
Termination by the Executive. The Executive’s employment by the Company and the Period of Employment, may be terminated
by the Executive, with or without Good Reason, upon not less than thirty (30) days prior written notice to the Company; provided, however,
that in the case of a termination for Good Reason (as such term is defined in Exhibit A), the Executive may provide immediate
written notice of termination once the applicable cure period (as contemplated by the definition of Good Reason) has lapsed if the Company
has not reasonably cured the circumstances that gave rise to the basis for the Good Reason termination.

 

5.3
Benefits Upon Termination.  If the Executive’s employment by the Company is terminated during the Period of Employment
for any reason by the Company or by the Executive, or upon or following the expiration of the Period of Employment (in any case, the
date that the Executive’s employment by the Company terminates is referred to as the “Termination Date”), the
Company shall have no further obligation to make or provide to the Executive, and the Executive shall have no further right to receive
or obtain from the Company, any payments or benefits except as follows:

 

(a)
the Company shall pay the Executive (or, in the event of the Executive’s death, the Executive’s estate) any Accrued Obligations
(as such term is defined in Exhibit A).

 

(b)
If, during the Period of Employment, the Executive’s employment with the Company is terminated by the Company without Cause (and
other than due to the Executive’s death or Disability), or as a result of a resignation by the Executive for Good Reason, and in
each case other than in the circumstances described in Section 5.3(c) below, the Company shall pay the Executive (in addition to the
Accrued Obligations) the following:

 

    4

     

    

 

(i)
subject to tax withholding and other authorized deductions, an amount equal to the greater of (A) the Executive’s Base Salary
and Automobile Allowance that would have been paid to the Executive had the Executive’s employment with the Company continued from
the Termination Date and through the Expiration Date, based on the annualized rate of Base Salary and Automobile Allowance in effect
on the Termination Date (without regard to any reduction in Base Salary level that results in a Good Reason termination), and (B) twelve
(12) months of the Executive’s Base Salary and Automobile Allowance at the rate in effect on the Termination Date (without regard
to any reduction in Base Salary level that results in a Good Reason termination). Such amount is referred to hereinafter as the “Severance
Benefit.” Subject to Section 18.1, the Company shall pay the Severance Benefit to the Executive in equal monthly installments
(rounded down to the nearest whole cent) over a period of twelve (12) consecutive months or, if longer, the number of months remaining
in the period between the Termination Date and the Expiration Date (the longer of such periods, the “Severance Period”),
with the first installment payable on (or within ten (10) days following) the sixtieth (60th) day following the Executive’s Separation
from Service (as such term is defined in Exhibit A) occurs (and which amount shall include payment of any amounts that would otherwise
be due prior thereto); and

 

(ii)
if the Executive and any of the Executive’s eligible dependents, in each case, who participate in the Company’s (or any Affiliate’s)
medical, dental, vision and prescription drug plans as of the Termination Date, timely elect coverage under Consolidated Omnibus Budget
Reconciliation Act (“COBRA”) for such plans, the Company shall pay directly, or reimburse Executive for, such COBRA
premiums (on a monthly basis) during the Severance Period; provided, that in no event shall the Company’s obligations pursuant
to this paragraph extend beyond the period in which the Company (or any Affiliate) is required to provide COBRA coverage to the Executive
and/or any of his eligible dependents; and provided, further, that the first payment or reimbursement shall be made on the sixtieth
(60th) day following the Executive’s Separation from Service (and which amount shall include payment of any amounts that would
otherwise be due prior thereto).

 

(c)
If at any time after the date that is twelve (12) months before the Expiration Date and on or before the date that is six (6) months
before the Expiration Date, the Company notifies the Executive that the Period of Employment will not be extended beyond the Expiration
Date as contemplated by Section 2 and the Executive’s employment actually terminates on the Expiration Date, the Executive will
be entitled to, subject to tax withholding and other authorized deductions, payment of an amount equal to (i) twelve (12) months of the
Executive’s Base Salary and Automobile Allowance at the rate in effect on the date of such notice, multiplied by (ii) a fraction,
the numerator of which is the number of calendar days of the Period of Employment that elapse between the date that is twelve (12) months
before the Expiration Date and the date on which such notice is provided to the Executive and the denominator of which is three hundred
sixty-five (365) (the “Non-Renewal Benefit”). Subject to Section 18.1, the Company shall pay such amount to the Executive
in equal monthly installments (rounded down to the nearest whole cent) over the corresponding number months, with the first installment
payable on (or within ten (10) days following) the sixtieth (60th) day following the Expiration Date (and which amount shall include
payment of any amounts that would otherwise be due prior thereto).

 

    5

     

    

 

(d)
If, during the Period of Employment, the Executive’s employment with the Company terminates due to the Executive’s death
or Disability, the Executive (or his estate) will be entitled to, subject to tax withholding and other authorized deductions, payment
of an amount equal to fifty percent (50%) of the Executive’s Base Salary at the annualized rate in effect on the Termination Date.
Subject to Section 18.1, the Company shall pay such amount to the Executive (or his estate) in equal monthly installments (rounded down
to the nearest whole cent) over a period of six (6) months, with the first installment payable on (or within ten (10) days following)
the sixtieth (60th) day following the Executive’s Separation from Service (and which amount shall include payment of any amounts
that would otherwise be due prior thereto).

 

(e)
If, during the Period of Employment, the Executive’s employment with the Company is terminated by the Company without Cause, as
a result of a resignation by the Executive for Good Reason or due to his death or Disability, the Executive (or his estate) will be entitled
to receive, subject to tax withholding and other authorized deductions, an amount equal to a pro-rated share of any Annual Incentive
Bonus otherwise payable to the Executive, for the year in which the Termination Date occurs (such proration to be based on the number
of days in the year of such termination of employment which the Executive is employed by the Company).

 

(f)
Notwithstanding the foregoing provisions of this Section 5.3, if the Executive materially breaches, at any time, either the Executive’s
obligations under Sections 6.1, 6.4, 6.5 or 6.6 of this Agreement or any other material provisions under Section 6 of this Agreement,
from and after the date of such breach and not in any way in limitation of any right or remedy otherwise available to the Company, the
Executive shall no longer be entitled to, and the Company shall no longer be obligated to pay, any remaining unpaid portion of the Severance
Benefit under Section 5.3(b) or any remaining unpaid portion of the severance payments under Section 5.3(c) or 5.3(d), as applicable;
provided, however, that, if the Executive provides the Release contemplated by Section 5.4, in no event shall the Executive
be entitled to a Severance Benefit payment of less than $5,000, which amount the parties agree is good and adequate consideration, in
and of itself, for the Executive’s Release contemplated by Section 5.4.

 

(g)
The foregoing provisions of this Section 5.3 shall not affect: (i) the Executive’s receipt of benefits otherwise due terminated
employees under group insurance coverage consistent with the terms of the applicable Company welfare benefit plan; (ii) the Executive’s
rights under COBRA to continue participation in medical, dental, hospitalization and life insurance coverage; (iii) the Executive’s
receipt of benefits otherwise due in accordance with the terms of the Company’s 401(k) plan (if any) or any other retirement or
pension plan; and (iv) any right to indemnification the Executive may have from the Company or the Executive’s right to be covered
under any applicable insurance policy, with respect to any liability the Executive incurred or might incur as an employee, officer or
director of the Company or its affiliates, including, without limitation, pursuant to Section 19 hereof.

 

    6

     

    

 

5.4
Release; Exclusive Remedy.

 

(a)
This Section 5.4 shall apply notwithstanding anything else contained in this Agreement to the contrary. As a condition precedent to any
Company obligation to the Executive pursuant to Section 5.3, the Executive (or his estate or personal representative, as applicable)
shall, upon or promptly following his last day of employment with the Company, provide the Company with a valid, executed written release
agreement in the form attached hereto as Exhibit C (with such changes as may be reasonably required to such form in order to make
the release enforceable and otherwise compliant with applicable law) (the “Release”), and such Release shall have
not been revoked by the Executive pursuant to any revocation rights afforded by applicable law. The Company shall provide the Release
to the Executive not later than seven (7) days following the Termination Date, and the Executive shall be required to execute and return
the Release to the Company within twenty-one (21) days (or forty-five (45) days if such longer period of time is required to make the
Release maximally enforceable under applicable law) after the Company provide the form of Release to the Executive.

 

(b)
The Executive agrees that the payments and benefits contemplated by Section 5.3 shall (if the Release contemplated by Section 5.4(a)
is signed and becomes effective and the severance amounts are paid in accordance with their terms) constitute the exclusive and sole
remedy for any termination of the Executive’s employment and, in such case, the Executive covenants not to assert or pursue any
other remedies, at law or in equity, with respect to any termination of employment; provided, however, that nothing herein
shall affect Executive’s rights as a stockholder of the Company (or the rights of any stockholder in which Executive has a direct
or indirect beneficial interest). The Company and the Executive acknowledge and agree that there is no duty of the Executive to mitigate
damages under this Agreement, and there shall be no offset against any amounts due to the Executive under this Agreement on account of
any remuneration attributable to any subsequent employment that the Executive may obtain. All amounts paid to the Executive pursuant
to Section 5.3 shall be paid without regard to whether the Executive has taken or takes actions to mitigate damages. The Executive agrees
to resign, on the Termination Date, as an officer and director of the Company and any Affiliate, and as a fiduciary of any benefit plan
of the Company or any Affiliate, and to promptly execute and provide to the Company any further documentation, as reasonably required
by the Company, to confirm such resignation.

 

5.5.
Notice of Termination; Paid Leave. Any termination of the Executive’s employment under this Agreement shall be communicated
by written notice of termination from the terminating party to the other parties. This notice of termination must be delivered in accordance
with Section 17 and must indicate the specific provision(s) of this Agreement relied upon in effecting the termination. If the Company
terminates the Executive’s employment pursuant to clause (b) of Section 5.1, or if the Executive provides notice of termination
pursuant to Section 5.2, the Company may place the Executive on paid administrative leave during the applicable notice period and such
leave shall not constitute grounds for a resignation by the Executive for Good Reason.

 

    7

     

    

 

5.6
Section 280G.  In the event that the payments and benefits provided under this Agreement and benefits provided to, or for
the benefit of, the Executive under any other Company plan or agreement (such payments or benefits are collectively referred to as the
“Benefits”) would be subject to the excise tax (the “Excise Tax”) imposed under Section 4999 of
the Internal Revenue Code of 1986, as amended (the “Code”) in connection with any transaction other than the transactions
contemplated by the Merger Agreement, and the Excise Tax applies with respect to the Executive’s compensation (if any) under the
Equity Incentive Plan, the Executive shall be entitled to an additional payment by the Company equal to seven and one-half percent (7.5%,
or 37.5% of 20%) of the difference obtained by subtracting the Executive’s “base amount” allocated to value or amounts
realized by the Executive under the Equity Incentive Plan that are considered parachute payments under Section 280G(b)(2) of the Code
and the regulations thereunder (the “Applicable Amounts”) (as such base amount is determined for purposes of Section
280G of the Code) from the Applicable Amounts.

 

For
purposes of clarity, such payment by the Company shall not be increased with respect to any tax liability incurred by the Executive with
respect to such payment; provided, however, that if such payment is triggered in connection with or following a termination of the Executive’s
employment, the Company’s obligation to make such payment shall be subject to the Executive’s satisfaction of the requirements
set forth in Sections 5.3(f) and 5.4. Any such payment by the Company pursuant to this Section 5.6 shall be made promptly after the Determination
described below is made and in all cases not later than the end of the Executive’s taxable year next following the year in which
the Executive remits the related taxes. A determination as to whether any Excise Tax would be imposed on the Benefits for purposes of
this Section 5.6, and the determination of any payment due to the Executive pursuant to this Section 5.6, shall be made by the Company’s
independent public accountants or another certified public accounting firm or executive compensation consulting firm of national reputation
designated by the Company (the “Firm”) at the Company’s expense. The Firm shall provide its determination (the
“Determination”), together with detailed supporting calculations and documentation to the Company and the Executive
within ten (10) business days of the date of termination of the Executive’s employment, if applicable, or such other time as reasonably
requested by the Company or the Executive (provided the Executive reasonably believes that any of the Benefits may be subject to the
Excise Tax).

 

    8

     

    

 

6.
Protective Covenants.

 

6.1
Confidential Information. The Executive agrees that he will not disclose or use at any time, either during the Executive’s
employment with the Company or thereafter, any Confidential Information (as defined below) of which the Executive is or becomes aware,
whether or not such information is developed by the Executive, except to the extent that such disclosure or use is directly related to
the good faith performance of the Executive’s duties for the Company. The Executive agrees that he will take all reasonable and
appropriate steps to safeguard Confidential Information in his possession and to protect it against disclosure, misuse, espionage, loss
and theft. Notwithstanding the foregoing, the Executive may truthfully respond to a lawful and valid subpoena, court order or other legal
process, but the Executive agrees, to the extent he is permitted under applicable law and the relevant request for disclosure: (i) to
first give the Company the earliest possible notice thereof, (ii) to, as much in advance of the return date as possible, make available
to the Company and its counsel the documents and other reasonable information sought, and (iii) to assist the Company and such counsel
(at the Company’s expense) in resisting or otherwise responding to such process, subject to the Executive’s other commitments.
As used in this Agreement, the term “Confidential Information” means information that is not generally known to the
public and that is used, developed or obtained by the Company or any Subsidiary in connection with its business, including, but not limited
to, information, observations and data obtained by the Executive while employed by the Company or any predecessors thereof (including
those obtained prior to the date of this Agreement) concerning (i) the business or affairs of the Company or any Subsidiary (including
each of their respective predecessors), (ii) products or services, (iii) fees, costs and pricing structures, (iv) designs, (v) analyses,
(vi) drawings, photographs and reports, (vii) computer software, including operating systems, applications and program listings, (viii)
flow charts, manuals and documentation, (ix) data bases, (x) accounting and business methods, (xi) inventions, devices, new developments,
methods and processes, whether patentable or unpatentable and whether or not reduced to practice, (xii) customers and clients and customer
or client lists, (xiii) other copyrightable works, (xiv) all production methods, processes, technology and trade secrets, and (xv) all
similar and related information in whatever form. Confidential Information will not be deemed to have been published merely because individual
portions of the information have been separately published, but only if all material features comprising such information have been published
in combination. The Executive further understands that Confidential Information does not include any of the foregoing or other items
that have become publicly known or made generally available through no wrongful act (or failure to act) of the Executive or, to the knowledge
of the Executive, of others who were under confidentiality obligations as to the item or items involved or improvements or new versions
thereof or is available, or becomes available, to the Executive on a non-confidential basis, but only if the source of the information
is not, to the Executive’s knowledge, prohibited from transmitting the information to the Executive by a contractual, legal, fiduciary
or other obligation. The Executive acknowledges that, as between the Executive and the Company, all Confidential Information shall be
the sole and exclusive property of the Company and its assigns. Further, this Section 6.1 shall not prevent the Executive from disclosing
Confidential Information in connection with any litigation, arbitration or mediation involving the Executive’s employment or termination
thereof, including, but not limited to, enforcing this Agreement, provided that such disclosure is reasonably necessary for the Executive
to assert any claim or defense in such proceeding.

 

6.2
Inventions.

 

(a)
Inventions Retained and Licensed. The Executive has attached hereto, as Exhibit D, a list describing all inventions, original
works of authorship, developments, improvements and trade secrets that were made, conceived or first reduced to practice by the Executive
prior to his employment with the Company (collectively referred to as “Prior Inventions”), which belong to the Executive
or a third party (such as a former employer), which relate to the Company’s (or any Subsidiary’s) actual or proposed business,
products or research and development, and which are not assigned to the Company hereunder; or, if no such list is attached, the Executive
represents that there are no such Prior Inventions. If disclosure of any such Prior Invention would cause the Executive to violate any
prior confidentiality agreement, the Executive understands that he is not to list such Prior Inventions in Exhibit D but is only
to disclose a cursory name for each such invention, a listing of the party(ies) to whom it belongs and the fact that full disclosure
as to such inventions has not been made for that reason. A space is provided on Exhibit D for such purpose. If, in the course
of the Executive’s employment with the Company the Executive incorporates into a Company or Subsidiary product, material, process,
machine or service, a Prior Invention owned by the Executive or in which he has an interest, the Executive hereby grants to the Company
a nonexclusive, royalty-free, fully paid-up, irrevocable, perpetual, worldwide license (with rights to sublicense through multiple tiers
of sublicensees) to make, have made, modify, make derivative works of, use, disclose, reproduce, distribute, offer to sell, sell, have
sold, import and otherwise exploit such Prior Invention as part of or in connection with such product, material, process, machine or
service, and to practice any method related thereto. Notwithstanding the foregoing, the Executive agrees that he will not incorporate,
or permit to be incorporated, Prior Inventions in any Company or Subsidiary product, material, process, machine or service without the
Company’s prior written consent.

 

    9

     

    

 

(b)
Assignment of Inventions. The Executive agrees that he will promptly make full written disclosure to the Company, will hold in
trust for the sole right and benefit of the Company and hereby assigns to the Company, or its designee, all the Executive’s right,
title and interest in and to any and all inventions, original works of authorship, developments, concepts, improvements, designs, mask
works, prototypes, models, materials, discoveries, ideas, processes, formulas, data, know-how, techniques, trademarks or trade secrets,
whether or not patentable or registrable under copyright or similar laws, which the Executive may solely or jointly conceive or develop
or reduce to practice, or cause to be conceived or developed or reduced to practice, during the entire period of time the Executive is
in the employ of the Company, whether before or after the execution of this Agreement, except as provided in Section 6.2(f) below (collectively
referred to as “Inventions”). Notwithstanding anything to the contrary contained herein, for purposes of this Agreement,
Inventions shall not include inventions created by the Executive during non-business hours that are not related in any respect to the
business (or any portion thereof) of the Company. The Executive further acknowledges that all original works of authorship that are made
by the Executive (solely or jointly with others) within the scope of and during the period of his employment with the Company (whether
before or after the execution of this Agreement) and which are protectable by copyright are “works made for hire,” as that
term is defined in the United States Copyright Act. Additionally, any assignment of copyright hereunder includes all rights of paternity,
integrity, disclosure and withdrawal and any other rights that may be known as or referred to as “moral rights” (collectively
“Moral Rights”). To the extent such Moral Rights cannot be assigned under applicable law and to the extent the following
is allowed by the laws in the various countries where Moral Rights exist, the Executive hereby waives such Moral Rights and consents
to any action of the Company that would violate such Moral Rights in the absence of such consent. The Executive will confirm any such
waivers and consents from time to time as requested by the Company. The Executive understands and agrees that the decision whether or
not to commercialize or market any invention developed by the Executive solely or jointly with others is within the Company’s sole
discretion and for the Company’s sole benefit and that no royalty will be due to the Executive as a result of the Company’s
efforts to commercialize or market any such invention.

 

(c)
Inventions Assigned to the United States. The Executive agrees to assign to the United States government all the Executive’s
right, title and interest in and to any and all Inventions whenever such full title is required to be in the United States by a contract
between the Company, on the one hand, and the United States or any of its agencies, on the other hand.

 

(d)
Maintenance of Records. The Executive agrees to keep and maintain adequate and current written records of all Inventions made
by the Executive (solely or jointly with others) during the term of his employment with the Company. The records will be in the form
of notes, notebooks, sketches, drawings or any other format that may be reasonably specified by the Company. The records will be available
to, and remain the sole property of the Company at all times.

 

    10

     

    

 

(e)
Registrations and Enforcement. The Executive agrees to reasonably assist the Company, or its designee, at the Company’s
expense, in every proper way to secure, maintain, defend and enforce the Company’s rights in the Inventions and any copyrights,
patents, mask work rights or other intellectual property rights relating thereto in any and all countries, including the disclosure to
the Company of all pertinent information and data with respect thereto, the execution of all applications, specifications, oaths, assignments
and all other instruments which the Company shall deem necessary in order to apply for and obtain such rights and in order to assign
and convey to the Company or any successors, assigns and nominees the sole and exclusive rights, title and interest in and to such Inventions,
and any copyrights, patents, mask work rights or other intellectual property rights relating thereto. The Executive further agrees that
his obligation to execute or cause to be executed, when it is in his power to do so, any such instrument or papers shall continue after
the termination of this Agreement, but the Company shall compensate the Executive at a reasonable rate after his termination for the
time actually spent by him at the Company’s request on such assistance. If the Company is unable because of the Executive’s
mental or physical incapacity or for any other reason to secure his signature in connection with any of the foregoing actions (including
as necessary to apply for or to pursue any application for any United States or foreign patents or copyright registrations covering Inventions
or original works of authorship assigned to the Company as above), then the Executive hereby irrevocably designates and appoints the
Company and its duly authorized officers and agents as his agent and attorney in fact, to act for and in his behalf and stead (including
to execute and file any such applications and to do all other lawfully permitted acts to further the prosecution and issuance of letters
patent or copyright registrations thereon) with the same legal force and effect as if executed by the Executive. The Executive hereby
waives and quitclaims to the Company any and all claims, of any nature whatsoever, which the Executive now or may hereafter have for
infringement of any Inventions assigned hereunder to the Company.

 

(f)
Obligation to Keep Company Informed. During the Period of Employment and for six (6) months after the Executive’s Termination
Date, the Executive will promptly disclose to the Company fully and in writing all Inventions authored, conceived or reduced to practice
by the Executive, either alone or jointly with others. In addition, the Executive will promptly disclose to the Company all patent applications
filed by him or on his behalf within a year after the Termination Date.

 

6.3
Cooperation. For the greater of one (1) year and the Severance Period following the Executive’s last day of employment
by the Company, the Executive shall reasonably cooperate with the Company and the Subsidiaries in connection with: (a) any internal or
governmental investigation or administrative, regulatory, arbitral or judicial proceeding involving any of them with respect to matters
relating to the Executive’s employment with or service as a member of the Board or the board of directors of any Subsidiary; or
(b) any audit of the financial statements of the Company or any Subsidiary with respect to the period of time when the Executive was
employed by the Company. The Company shall reimburse the Executive for reasonable travel expenses incurred in connection with providing
the services under this Section 6.3, including lodging and meals, upon the Executive’s submission of receipts.

 

    11

     

    

 

6.4
Restriction on Competition. The Executive agrees that if the Executive were to become employed by, or substantially involved
in, the business of a competitor of the Company or any of the Subsidiaries during the Restricted Period (defined below), it would be
very difficult for the Executive not to rely on or use the Company’s or the Subsidiaries’ trade secrets and confidential
information. Thus, to avoid the inevitable disclosure of such trade secrets and confidential information, and to protect such trade secrets
and confidential information and the Company’s and the Subsidiaries’ relationships and goodwill with customers, during the
Restricted Period, except in the good faith performance of his duties hereunder, the Executive shall not directly or indirectly through
any other Person engage in, enter the employ of, render any services to, have any ownership interest in, nor participate in the financing,
operation, management or control of, any Competing Business. For purposes of this Agreement, “Restricted Period” means
the Period of Employment and (a) if the Executive’s employment with the Company is terminated by the Company with Cause or by the
Executive without Good Reason, two (2) years after the Termination Date; or (b) otherwise, the period of time over which a Severance
Benefit or Non-Renewal Benefit is payable to the Executive under Section 5.3. For purposes of this Agreement, the phrase “directly
or indirectly through any other Person engage in” shall include, without limitation, any direct or indirect ownership or profit
participation interest in such enterprise, whether as an owner, stockholder, member, partner, joint venturer or otherwise, and shall
include any direct or indirect participation in such enterprise as an employee, consultant, director, officer, licensor of technology
or otherwise. For purposes of this Agreement, “Competing Business” means any Person anywhere in the United States
and any other country in which the Company or any of the Subsidiaries operates (or plans to commence operations) that at any time during
the Period of Employment is engaged in (or has plans to engage in), or at any time during the six (6) month period following the Termination
Date is engaged in (or has plans to engage in) a business related to bowling or the operation of bowling centers. Nothing herein shall
prohibit the Executive from (i) investing in mutual funds and stocks, bonds, or other securities in any business if such stocks, bonds,
or other securities are listed on any securities exchange or are publicly traded in an over the counter market, and such investment does
not exceed, in the case of any capital stock of any one issuer, two percent (2%) of the issued and outstanding capital stock or in the
case of bonds or other securities, two percent (2%) of the aggregate principal amount thereof issued and outstanding, or (ii) being employed
in a senior management role of a conglomerate (or a portion of a conglomerate) that engages in a Competing Business so long as the Executive
does not perform services to or otherwise actively participate in the business unit engaged in the Competing Business.

 

6.5
Soliciting Customers. During the Restricted Period, the Executive shall not directly or indirectly through any other Person
influence or attempt to influence customers, vendors, suppliers, licensors, lessors, joint venturers, associates, consultants, agents,
or partners of the Company or any of the Subsidiaries to divert their business away from the Company, or such Subsidiary to a Competing
Business, and the Executive shall not otherwise interfere with, disrupt or attempt to disrupt the business relationships, contractual
or otherwise, between the Company or any of the Subsidiaries, on the one hand, and any of its or their customers, suppliers, vendors,
lessors, licensors, joint venturers, associates, officers, employees, consultants, managers, partners, members or investors, on the other
hand in an effort to benefit a Competing Business. The foregoing shall not be violated by general advertising of a customary nature not
targeted at such persons or entities, nor by serving as a reasonable and customary reference upon request.

 

    12

     

    

 

6.6
Soliciting Employees and Consultants. During the Restricted Period, except in the good faith performance of his duties hereunder,
the Executive shall not directly or indirectly through any other Person (a) induce or attempt to induce any officer, other key employee
or independent contractor of the Company or any of the Subsidiaries to leave the employ or service, as applicable, of the Company or
such Subsidiary, or in any way interfere with the relationship between the Company or any Subsidiary, on the one hand, and any officer,
other key employee or independent contractor thereof, on the other hand, or (b) hire any person who was an officer or other key employee
of the Company or any of the Subsidiaries until six (6) months after such individual’s employment relationship with the Company
or such Subsidiary has been terminated. For purposes of this Section 6.6, any employee of the Company or any of the Subsidiaries whose
compensation for the year in which such event occurs is or is reasonably expected to be greater than $80,000 shall be presumed to be
a “key employee.” The foregoing shall not be violated by general advertising of a customary nature not targeted at such persons
or entities, nor by serving as a reasonable and customary reference upon request.

 

6.7
Understanding of Covenants.

 

(a)
The Executive acknowledges that, in the course of the Executive’s employment with the Company and/or its Subsidiaries and their
predecessors, the Executive has become familiar, or will become familiar, with the Company’s and the Subsidiaries’ and their
predecessors’ trade secrets and with other confidential and proprietary information concerning the Company, the Subsidiaries and
their respective predecessors and that the Executive’s services have been and will be of special, unique and extraordinary value
to the Company and the Subsidiaries. The Executive agrees that the foregoing covenants set forth in Sections 6.2 through 6.4 (together,
the “Restrictive Covenants”) are reasonable and necessary to protect the Company’s and the Subsidiaries’
trade secrets and other confidential and proprietary information, good will, stable workforce, and customer relations.

 

(b)
Without limiting the generality of the Executive’s agreement in the preceding paragraph, the Executive (i) represents that the
Executive is familiar with and has carefully considered the Restrictive Covenants, (ii) represents that the Executive is fully aware
of the Executive’s obligations hereunder, (iii) agrees to the reasonableness of the length of time, scope and geographic coverage,
as applicable, of the Restrictive Covenants, and (iv) agrees that the Restrictive Covenants shall continue in effect for the applicable
periods set forth above in this Section 6 regardless of whether the Executive is then entitled to receive severance pay or benefits from
the Company. The Executive understands that the Restrictive Covenants may limit the Executive’s ability to earn a livelihood in
a business similar to the business of the Company, and the Subsidiaries, but the Executive nevertheless believes that the Executive has
received and will receive sufficient consideration and other benefits as an employee of the Company to justify such restrictions and
that such restrictions would prevent the Executive from otherwise earning a living. The Executive acknowledges and agrees that the Restrictive
Covenants do not confer a benefit upon the Company and the Subsidiaries disproportionate to the detriment of the Executive; are not greater
than is required to protect the legitimate and valid business interests and goodwill of the Company and the Subsidiaries; are reasonably
necessary to prevent unfair competition; and are not injurious to the public.

 

    13

     

    

 

6.8
Enforcement and Venue for Enforcement. The Executive agrees that the Executive’s services are unique and that the Executive
has access to the Company’s and the Subsidiaries’ trade secrets and other confidential and proprietary information. Accordingly,
the Executive agrees that a breach by the Executive of any of the covenants in this Section 6 would cause immediate and irreparable harm
to the Company that would be difficult or impossible to measure, and that damages to the Company for any such injury would therefore
be an inadequate remedy for any such breach. Therefore, the Executive agrees that in the event of any breach or threatened breach of
any provision of this Section 6, the Company shall be entitled, in addition to and without limitation upon all other remedies that either
of them may have under this Agreement, at law or otherwise, to obtain specific performance, injunctive relief and/or other appropriate
relief (without posting any bond or deposit) in order to enforce or prevent any violations of the provisions of this Section 6. The Executive
further agrees that the applicable period of time any Restrictive Covenant is in effect following the Termination Date, as determined
pursuant to the foregoing provisions of this Section 6, such period of time shall be extended by the same amount of time that Executive
is in breach of any Restrictive Covenant. The Executive further understands and agrees that any court action brought pursuant to this
Section 6.6 will be brought in federal or state court of New York, and hereby expressly consents to the jurisdiction of such courts for
that purpose. Notwithstanding anything herein to the contrary, (A) the Company shall not be entitled to assert or pursue any remedies
(whether at law or in equity), including, without limitation, specific performance, injunctive relief and/or any other relief or remedy
in order to enforce or prevent any violations or breaches of the provisions of Sections 6.4 through 6.6 of this Agreement that occur
on and after the 24-month anniversary of the Termination Date, and (B) the Company’s cessation of any remaining payments and benefits
payable to the Executive under Section 5.3(b) of this Agreement shall constitute the exclusive and sole remedy for any such breach.

 

6.9
Return of Company Materials. The Executive agrees that, at the time of leaving the employ of the Company, the Executive will
deliver to the Company (and will not keep in the Executive’s possession, recreate or deliver to anyone else) any and all devices,
records, data, notes, notebooks, reports, proposals, lists, correspondence, specifications, drawings, blueprints, sketches, materials,
equipment, prototypes, samples, models and other documents or property, or reproductions of any aforementioned items developed by the
Executive pursuant to his employment with the Company or otherwise belonging to the Company, any Subsidiary, or their respective successors
or assigns; provided that the Executive may retain his telephone directories, compensation related documents and other personal property.

 

7.
Withholding Taxes. Notwithstanding anything else herein to the contrary, the Company may withhold (or cause there to be withheld,
as the case may be) from any amounts otherwise due or payable under or pursuant to this Agreement such federal, state and local income,
employment, or other taxes as may be required to be withheld pursuant to any applicable law or regulation.

 

    14

     

    

 

8.
Successors and Assigns. This Agreement is personal to Executive and without the prior written consent of the Company shall
not be assignable by Executive otherwise than by will or the laws of descent and distribution. This Agreement shall inure to the benefit
of and be enforceable by Executive’s legal representatives. This Agreement shall inure to the benefit of and be binding upon the
Company, its successors and, other than as set forth below, shall not be assignable by the Company without the prior written consent
of Executive. The obligations under this Agreement shall be assignable by the Company to, and only to, any successor (whether direct
or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business and/or assets of the Company;
provided, that the Company shall require such successor to expressly assume and agree to perform its obligations under this Agreement
in the same manner and to the same extent that the Company would be required to perform it if no such assignment had taken place; if
such successor fails to assume and agree to perform this Agreement in such manner and to such extent, such failure shall be grounds for
Executive to terminate his employment hereunder for Good Reason. As used in this Agreement, “Company” shall mean the Company
as hereinbefore defined and any successor thereto which assumes and agrees to perform this Agreement by operation of law or otherwise.

 

9.
Number and Gender; Examples. Where the context requires, the singular shall include the plural, the plural shall include the
singular, and any gender shall include all other genders. Where specific language is used to clarify by example a general statement contained
herein, such specific language shall not be deemed to modify, limit or restrict in any manner the construction of the general statement
to which it relates.

 

10.
Section Headings. The section headings of, and titles of paragraphs and subparagraphs contained in, this Agreement are for
the purpose of convenience only, and they neither form a part of this Agreement nor are they to be used in the construction or interpretation
thereof.

 

11.
Governing Law. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK, WITHOUT
GIVING EFFECT TO ANY CHOICE OF LAW OR CONFLICTING PROVISION OR RULE (WHETHER OF THE STATE OF NEW YORK OR ANY OTHER JURISDICTION) THAT
WOULD CAUSE THE LAWS OF ANY JURISDICTION OTHER THAN THE STATE OF NEW YORK TO BE APPLIED. IN FURTHERANCE OF THE FOREGOING, THE INTERNAL
LAW OF THE STATE OF NEW YORK WILL CONTROL THE INTERPRETATION AND CONSTRUCTION OF THIS AGREEMENT, EVEN IF UNDER SUCH JURISDICTION’S
CHOICE OF LAW OR CONFLICT OF LAW ANALYSIS, THE SUBSTANTIVE LAW OF SOME OTHER JURISDICTION WOULD ORDINARILY APPLY.

 

12.
Severability.  It is the desire and intent of the parties hereto that the provisions of this Agreement be enforced to the
fullest extent permissible under the laws and public policies applied in each jurisdiction in which enforcement is sought. Accordingly,
if any particular provision of this Agreement shall be adjudicated by a court of competent jurisdiction to be invalid, prohibited or
unenforceable under any present or future law, and if the rights and obligations of any party under this Agreement will not be materially
and adversely affected thereby, such provision, as to such jurisdiction, shall be ineffective, without invalidating the remaining provisions
of this Agreement or affecting the validity or enforceability of such provision in any other jurisdiction, and to this end the provisions
of this Agreement are declared to be severable; furthermore, in lieu of such invalid or unenforceable provision there will be added automatically
as a part of this Agreement, a legal, valid and enforceable provision as similar in terms to such invalid or unenforceable provision
as may be possible. Notwithstanding the foregoing, if such provision could be more narrowly drawn (as to geographic scope, period of
duration or otherwise) so as not to be invalid, prohibited or unenforceable in such jurisdiction, it shall, as to such jurisdiction,
be so narrowly drawn, without invalidating the remaining provisions of this Agreement or affecting the validity or enforceability of
such provision in any other jurisdiction.

 

    15

     

    

 

13.
Entire Agreement. On and following the Effective Date, (i) this Agreement, including its attachments and exhibits (together,
the “Integrated Document”), embodies the entire agreement of the parties hereto respecting the matters within its
scope, (ii) the Integrated Document supersedes all prior and contemporaneous agreements of the parties hereto that directly or indirectly
bears upon the subject matter hereof, including without limitation, any employment agreement with the Company, (iii) any prior negotiations,
correspondence, agreements, proposals or understandings relating to the subject matter hereof shall be deemed to have been merged into
the Integrated Document, and to the extent inconsistent herewith, such negotiations, correspondence, agreements, proposals, or understandings
shall be deemed to be of no force or effect, and (iv) there are no representations, warranties, or agreements, whether express or implied,
or oral or written, with respect to the subject matter hereof, except as expressly set forth herein or in the Integrated Document. Notwithstanding
any other provision herein, the Integrated Documents shall have no force or effect (except for this sentence) unless and until the Effective
Date (i.e., the time at which the transactions contemplated by the Merger Agreement are consummated).

 

14.
Modifications. This Agreement may not be amended, modified or changed (in whole or in part), except by a formal, definitive
written agreement expressly referring to this Agreement, which agreement is executed by both of the parties hereto. The Executive may
not consent to any such amendment, modification or change on behalf of the Company.

 

15.
Waiver. Neither the failure nor any delay on the part of a party to exercise any right, remedy, power or privilege under this
Agreement shall operate as a waiver thereof, nor shall any single or partial exercise of any right, remedy, power or privilege preclude
any other or further exercise of the same or of any right, remedy, power or privilege, nor shall any waiver of any right, remedy, power
or privilege with respect to any occurrence be construed as a waiver of such right, remedy, power or privilege with respect to any other
occurrence. No waiver shall be effective unless it is in writing and is signed by the party asserted to have granted such waiver.

 

16.
Arbitration; Waiver of Jury Trial.

 

16.1
Arbitration. The Executive and the Company hereby agree that any and all controversies, claims or disputes with anyone arising
out of, relating to or resulting in any manner from the Executive’s employment with the Company or the termination of the Executive’s
employment with the Company, including any breach of this Agreement, (including any dispute with any employee, officer, shareholder,
affiliate or benefit plan of the Company in their capacity as such or otherwise) shall be subject to binding arbitration under the arbitration
rules set forth in applicable state or federal law (the “Rules”). Disputes which the parties agree to arbitrate, and
thereby agree to waive any right to a trial by jury, include any statutory claims under state or federal law, including, but not limited
to, claims under Title VII of the Civil Rights Act of 1964, the Americans with Disabilities Act of 1990, the Age Discrimination in Employment
Act of 1967, the Older Workers Benefit Protection Act, claims of harassment, discrimination or wrongful termination and any statutory
claims.

 

    16

     

    

 

16.2
Procedure. The parties hereby agree that any arbitration will be administered by a sole arbitrator (the “Arbitrator”)
selected from Judicial Arbitration & Mediation Services, Inc., New York, New York, or its successor (“JAMS”),
or if JAMS is no longer able to supply the arbitrator, such arbitrator shall be selected from the American Arbitration Association, and
such selection shall be in a manner consistent with the JAMS rules applicable to employment disputes. Any arbitration pursuant to this
Section 16 shall take place in New York, New York. The parties agree that the Arbitrator shall have the power to decide any motions brought
by any party to the arbitration, including motions for summary judgment and/or adjudication and motions to dismiss and demurrers, prior
to any arbitration hearing. The parties also agree that the Arbitrator shall have the power to award any remedies, including attorneys’
fees and costs, available under applicable law. The Company agrees that it will pay for any administrative or hearing fees unique to
arbitration, including any filing fees or arbitrator fees associated with any arbitration brought under this Section 16. The Arbitrator
shall administer and conduct any arbitration in a manner consistent with the Rules and that to the extent that the JAMS rules applicable
to employment disputes conflict with the Rules, the Rules shall take precedence. The decision of the Arbitrator shall be in writing and
shall set forth the bases for the Arbitrator’s decision.

 

16.3
Remedy. Except as provided by the Rules and this Agreement, arbitration shall be the sole, exclusive and final remedy for
any dispute between the Executive and the Company. Accordingly, except as provided for by the Rules and this Agreement, the Executive
and the Company will not be permitted to pursue court action regarding claims that are subject to arbitration. Notwithstanding, the Arbitrator
will not have the authority to disregard or refuse to enforce any lawful Company policy, and the Arbitrator shall not order or require
the Company to adopt a policy not otherwise required by law which the Company has not adopted. The decision of the Arbitrator on any
issue, dispute, claim or controversy submitted for arbitration, shall be final and binding upon the parties and that judgment may be
entered on the award of the Arbitrator in any court having proper jurisdiction.

 

16.4
Availability of Injunctive Relief. In addition to the right under the Rules to petition the court for provisional relief,
the parties agree that any party may also petition the court for injunctive relief in aid of arbitration where either party alleges or
claims a violation of this Agreement or any other agreement between the Executive, on the one hand, and the Company, on the other hand,
regarding trade secrets or confidential information. The Executive understands that any breach or threatened breach of such an agreement
will cause irreparable injury and that money damages will not provide an adequate remedy therefor, and both parties hereby consent to
the issuance of an injunction. In the event either party seeks injunctive relief, the prevailing party shall be entitled to recover reasonable
costs and attorneys’ fees to the extent permitted by applicable law.

 

    17

     

    

 

16.5 Administrative
Relief. The Executive understands that this Agreement does not prohibit the Executive from pursuing an administrative claim with
a local, state or federal administrative body such as the Equal Employment Opportunity Commission or the state Workers’ Compensation
board. This Agreement does, however, preclude the Executive from pursuing court action regarding any such claim.

 

16.6 Waiver
of Jury Trial. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM
ARISING OUT OF OR RELATING TO THIS AGREEMENT.

 

17. Notices.
Any notice provided for in this Agreement must be in writing and must be either personally delivered, transmitted via telecopier,
mailed by first class mail (postage prepaid and return receipt requested) or sent by reputable overnight courier service (charges prepaid)
to the recipient at the address below indicated or at such other address or to the attention of such other person as the recipient party
has specified by prior written notice to the sending party. Notices will be deemed to have been given hereunder and received when delivered
personally, when received if transmitted via telecopier, five days after deposit in the U.S. mail and one day after deposit with a reputable
overnight courier service.

 

if
to the Company:

 

Bowlmor
AMF Corp.

Attention:
Brett I. Parker

222
West 44th Street

New
York, New York 10036

 

With
a copy to:

 

		 	 
	 	 	 
	 	 	 

 

if
to the Executive, to the address most recently on file in the Company’s payroll records, with a copy to:

 

Proskauer
Rose LLP

11
Times Square

New
York, NY 10036

Attn:
Ira Bogner, Esq.

 

    18

     

    

 

18.
Section 409A.

 

18.1 If
the Executive is a “specified employee” within the meaning of Treasury Regulation Section 1.409A-1(i) as of the date of the
Executive’s Separation from Service, the Executive shall not be entitled to any payment or benefit pursuant to Section 5.3 until
the earlier of (i) the date which is six (6) months after the Executive’s Separation from Service for any reason other than death,
or (ii) the date of the Executive’s death. The provisions of this Section 18.1 shall only apply if, and to the extent, required
to avoid the imputation of any tax, penalty or interest pursuant to Section 409A of the Internal Revenue Code of 1986, as amended (the
“Code”). Any amounts otherwise payable to the Executive upon or in the six (6) month period following the Executive’s
Separation from Service that are not so paid by reason of this Section 18.1 shall be paid (without interest) as soon as practicable (and
in all events within thirty (30) days) after the date that is six (6) months after the Executive’s Separation from Service (or,
if earlier, as soon as practicable, and in all events within thirty (30) days, after the date of the Executive’s death).

 

18.2 Except
to the extent any reimbursement or in-kind benefit provided pursuant to this Agreement does not constitute a “deferral of compensation”
within the meaning of Section 409A of the Code, any such reimbursement or in-kind benefit due to the Executive hereunder (A) shall be
paid to the Executive on or before the last day of the Executive’s taxable year following the taxable year in which the related
expense was incurred, and (B) shall not be subject to liquidation or exchange for another benefit and the amount of such reimbursement
or in-kind benefit that the Executive receives in one taxable year shall not affect the amount of such benefits and reimbursements that
the Executive receives in any other taxable year. Tax gross-up payments under this Agreement, if any, shall be paid in no event later
than the end of the calendar year following the calendar year in which the Executive pays such tax. The Executive agrees to promptly
submit and document any reimbursable expenses in accordance with the Company’s expense reimbursement policies to facilitate the
timely reimbursement of such expenses.

 

18.3
It is intended that any amounts payable under this Agreement and the Company’s, and the Executive’s exercise of authority
or discretion hereunder shall comply with and avoid the imputation of any tax, penalty or interest under Section 409A of the Code. This
Agreement shall be construed and interpreted consistent with that intent.

 

18.4 For
purposes of Section 409A of the Code, the Executive’s right to receive any installment payment under this Agreement shall be treated
as a right to receive a series of separate and distinct payments.

 

18.5 Notwithstanding
anything to the contrary herein, a termination of employment shall not be deemed to have occurred for purposes of any provision of this
Agreement providing for the payment of amounts or benefits upon or following a termination of employment unless such termination is also
a Separation from Service and, for purposes of any such provision of this Agreement, references to a “resignation,” “termination,”
“termination of employment” or like terms shall mean Separation from Service.

 

    19

     

    

 

19.
Indemnification.

 

19.1 The
Company agrees that (i) if the Executive is made a party, or is threatened to be made a party, to any threatened or actual action, suit
or proceeding whether civil, criminal, administrative, investigative, appellate or other (a “Proceeding”) by reason
of the fact that he is or was a director, officer or employee of the Company or is or was serving at the request of the Company as a
director, officer, member, employee, agent, manager, consultant or representative of another person or (ii) if any claim, demand, request,
investigation, controversy, threat, discovery request or request for testimony or information (a “Claim”) is made,
or threatened to be made, that arises out of or relates to the Executive’s service in any of the foregoing capacities, whether
arising before or after the Effective Date, then the Executive shall promptly be indemnified and held harmless by the Company to the
fullest extent legally permitted and authorized by the Company’s charter, bylaws or Board resolutions against any and all costs,
expenses, liabilities and losses (including, without limitation, attorney’s fees, judgments, interest, expenses of investigating,
defending or obtaining indemnity with respect to any Proceeding or Claim, penalties, fines, ERISA excise taxes or penalties and amounts
paid or to be paid in settlement) incurred or suffered by the Executive in connection therewith, and such indemnification shall continue
as to the Executive even if he has ceased to be a director, officer or employee of the Company or a director, officer, member, employee,
agent, manager, consultant or representative of such other person and shall inure to the benefit of the Executive’s heirs, executors
and administrators. To the extent permitted by law, the Company shall advance to the Executive all costs and expenses incurred by him
in connection with any such Proceeding or Claim within thirty (30) days after receiving written notice requesting such an advance. Such
notice shall include an undertaking by the Executive to repay the amount advanced if he is ultimately determined not to be entitled to
indemnification against such costs and expenses.

 

19.2 Neither
the failure of the Company (including its Board, independent legal counsel or stockholders) to have made a determination in connection
with any request for indemnification or advancement under Section 19.1 that the Executive has satisfied any applicable standard of conduct,
nor a determination by the Company (including its Board, independent legal counsel or stockholders) that the Executive has not met any
applicable standard of conduct, shall create a presumption that the Executive has not met an applicable standard of conduct.

 

19.3 During
the Period of Employment and for a period of three (3) years thereafter, the Company shall keep in place a directors and officers’
liability insurance policy (or policies) providing comprehensive coverage to the Executive if and to the extent that the Company provides
such coverage for any other present or former senior executive or director of the Company.

 

19.4 The
provisions of this Section 19 shall apply to the estate, executor, administrator, heirs, legatees or devisees of the Executive and shall
survive any termination of this Agreement.

 

20. Counterparts.
This Agreement may be executed in any number of counterparts, each of which shall be deemed an original as against any party whose
signature appears thereon, and all of which together shall constitute one and the same instrument. This Agreement shall become binding
when one or more counterparts hereof, individually or taken together, shall bear the signatures of all of the parties reflected hereon
as the signatories. Photographic copies of such signed counterparts may be used in lieu of the originals for any purpose.

 

    20

     

    

 

21. Legal
Counsel; Mutual Drafting. Each party recognizes that this is a legally binding contract and acknowledges and agrees that such
party has had the opportunity to consult with legal counsel of such party’s choice. Each party has cooperated in the drafting,
negotiation and preparation of this Agreement. Hence, in any construction to be made of this Agreement, the same shall not be construed
against either party on the basis of that party being the drafter of such language. The Executive agrees and acknowledges that the Executive
has read and understands this Agreement, is entering into it freely and voluntarily, and has been advised to seek counsel prior to entering
into this Agreement and has had ample opportunity to do so.

 

22. Further
Assurances. Each party shall execute and cause to be delivered to each other party hereto such documents and other instruments
and take such further actions as may be reasonably necessary to carry out the provisions hereof.

 

 

[The
remainder of this page has intentionally been left blank.]

 

    21

     

    

 

IN
WITNESS WHEREOF, the Company and the Executive have executed this Agreement as of the Effective Date.

 

		“COMPANY”
	 	 	 
	 	BOWLMOR
                                        AMF CORP.

                                        a Delaware corporation
	 	 	 
	 	By:	/s/
                                            Brett I. Parker
	 	Name:	Brett
                                            I. Parker
	 	Title:	Chief
                                            Financial Officer
	 	 	 
	 	 	 
	 	“EXECUTIVE”
	 	 	 
	 	 
	 	Thomas
                                        F. Shannon

 

 

Signature
Page to Employment Agreement

 

    22

     

    

 

IN
WITNESS WHEREOF, the Company and the Executive have executed this Agreement as of the Effective Date.

 

		“COMPANY”
	 	 	 
	 	BOWLMOR
                                        AMF CORP.

                                        a Delaware corporation
	 	 	 
	 	By:	
	 	Name:	Brett
                                            I. Parker
	 	Title:	Chief
                                            Financial Officer
	 	 	 
	 	 	 
	 	“EXECUTIVE”
	 	 	 
	 	/s/
                                        Thomas F. Shannon
	 	Thomas
                                        F. Shannon

 

 

Signature
Page to Employment Agreement

 

    23

     

    

 

EXHIBIT
A

 

Certain
Definitions

 

For
purposes of this Agreement the following terms have the following meanings:

 

“Accrued
Obligations” means:

 

		(i)	any
                                            Base Salary that had accrued but had not been paid (including accrued and unpaid vacation
                                            time) on or before the Termination Date; and

 

		(ii)	other
                                            than in the event of Executive’s termination by the Company for Cause or by Executive
                                            without Good Reason, any Annual Incentive Bonus payable pursuant to Section 3.2 with respect
                                            to the fiscal year immediately preceding the fiscal year in which the Termination Date occurs
                                            that had not previously been paid, paid when Annual Incentive Bonus payments are made to
                                            active employees but in no event later than December 31 of the calendar year in which the
                                            Termination Date occurs;

 

		(iii)	any
                                            reimbursement due to the Executive pursuant to Section 4.2 for expenses incurred by the Executive
                                            through the Termination Date; and

 

		(iv)	any
                                            other amounts or benefits required to be paid or provided by law or under any employee benefit
                                            plan, program, policy or practice of the Company.

 

Subject
to Section 18, all amounts in (i), (ii) and (iii) shall be paid promptly after the Termination Date and the amounts and benefits in (iv)
shall be paid or provided in accordance with their terms.

 

“Affiliate”
means a Person that directly or indirectly through one or more intermediaries, controls, or is controlled by, or is under common control
with, the Company. As used in this definition, the term “control,” including the correlative terms “controlling,”
“controlled by” and “under common control with,” means the possession, directly or indirectly, of the power to
direct or cause the direction of management or policies (whether through ownership of securities or any partnership or other ownership
interest, by contract or otherwise) of a Person.

 

“Cause”
shall mean that, during the Period of Employment, any of the following events exists or has occurred:

 

		(i)	the
                                            Executive is convicted of, or pleads guilty or nolo contendre to, a felony (under
                                            the laws of the United States or any relevant state, or a similar crime or offense under
                                            the applicable laws of any relevant foreign jurisdiction);

 

		(ii)	the
                                            Executive willfully commits an act of fraud, dishonesty or other act of willful misconduct
                                            in the course of the Executive’s duties hereunder that has an adverse impact on the
                                            Company or any Affiliate that is not immaterial;

 

    A-1

     

    

 

		(iii)	the
                                            Executive willfully fails to perform the Executive’s duties under this Agreement or
                                            any other agreement with the Company and/or willfully fails to comply with reasonable directives
                                            of the Board, in either case after the Company has delivered to the Executive a written demand
                                            for performance which describes the basis for the Board’s belief that the Executive
                                            has violated the Executive’s obligations to the Company, or failed to comply with any
                                            such directives, as applicable, and the Executive fails to cure such alleged violation or
                                            failure within thirty (30) days after receipt of such notice; or

 

		(iv)	any
                                            material breach by the Executive of this Agreement or the Stockholders’ Agreement after
                                            the Company has delivered to the Executive a written notice which describes the basis for
                                            the Board’s belief that the Executive has materially breached this Agreement, and the
                                            Executive fails to cure such alleged breach within thirty (30) days after receipt of such
                                            notice.

 

However,
no act or failure to act, on the Executive’s part shall be considered “willful” unless done, or omitted to be done,
by the Executive not in good faith and without reasonable belief that the Executive’s action or omission was in the best interest
of the Company. A determination by the Board that Cause exists shall be effective only if approved by at least a majority of the Board
(not counting the Executive if he is then a member of the Board) voting in person at a meeting at which Executive is entitled to be present
(with counsel) and respond to any basis that may be asserted as constituting Cause (a summary of which shall be supplied to the Executive
in writing at least seven (7) days before any such meeting).

 

“Disability”
means a physical or mental impairment which has rendered the Executive unable to perform the essential functions of his employment with
the Company (with or without reasonable accommodation) for more than 180 calendar days in any 12-month period, unless a longer period
is required by federal or state law, in which case that longer period would apply. The determination of whether or not a Disability exists
for purposes of this Agreement shall be based upon the findings of a qualified medical doctor reasonably agreed to by the Company and
the Executive (or, in the event of the Executive’s incapacity, his legal representative). In the absence of agreement between the
Company and the Executive, each party shall nominate a qualified medical doctor, and the two doctors so nominated shall select a third
qualified medical doctor, who shall make the determination as to Disability. The Company shall bear the costs of any such determinations.

 

“Good
Reason” means a resignation by the Executive after the occurrence (without the Executive’s consent) of any one or more
of the following conditions caused by the Company:

 

		(i)	a
                                            diminution in the Executive’s rate of Base Salary or Automobile Allowance from the
                                            rate then in effect or any diminution in compensation due to Executive pursuant to Section
                                            3.2 or 3.3 hereof;

 

		(ii)	a
                                            material diminution in the Executive’s authority, duties, responsibilities or status,
                                            including, without limitation, any change in title or position such that the Executive is
                                            no longer the President and Chief Executive Officer of the Company of the Company (for avoidance
                                            of doubt, a change such that the Executive is no longer the Chairman of the Company will
                                            not be considered “Good Reason” hereunder);

 

    A-2

     

    

 

		(iii)	any
                                            failure to reelect the Executive to the Board or removal of the Executive from the Board
                                            (except in accordance with the terms of the Stockholders’ Agreement);

 

		(iv)	the
                                            failure of the Company to obtain the assumption in writing of its obligations to perform
                                            this Agreement by any successor (whether direct or indirect, by purchase, merger, consolidation
                                            or otherwise) to all or substantially all of the business and/or assets of the Company as
                                            contemplated by Section 8 hereof;

 

		(v)	a
                                            material change in the geographic location of the Executive’s principal office with
                                            the Company (for this purpose, a relocation of such office to a new location that is more
                                            than thirty (30) miles from the current location of the Company’s executive offices
                                            shall constitute a “material change”); or

 

		(vi)	a
                                            material breach by the Company of this Agreement;

 

provided,
however, that any such condition or conditions, as applicable, shall not constitute Good Reason unless both (x) the Executive provides
written notice to the Company of the condition claimed to constitute Good Reason within sixty (60) days after the Executive has (or reasonably
should have) knowledge of the initial existence of such condition(s), and (y) the Company fails to remedy such condition(s) within thirty
(30) days of receiving such written notice thereof; and provided, further, that in all events the termination of the Executive’s
employment with the Company shall not constitute a termination for Good Reason unless such termination occurs not more than one hundred
and twenty (120) days following the initial existence of the condition claimed to constitute Good Reason.

 

“Person”
shall be construed broadly and shall include, without limitation, an individual, a partnership, a limited liability company, a corporation,
an association, a joint stock company, a trust, a joint venture, an unincorporated organization and a governmental entity or any department,
agency or political subdivision thereof.

 

“Separation
from Service” means a “separation from service” (within the meaning of Section 409A of the Code).

 

“Subsidiary”
means any corporation or entity in which the Company owns or controls directly or indirectly fifty percent (50%) or more of the voting
power or economic interests of such corporation or entity.

 

    A-3

     

    

 

EXHIBIT
B

 

Incentive
Bonus Term Sheet

(attached)

 

 

    B-1

     

    

 

Term
Sheet

 

Bowlmor
AMF Corp. CEO & CFO Annual Bonus Plan

 

In
connection with the transactions contemplated by the Agreement and Plan of Merger (the “Merger Agreement”) by and
among A-B Parent LLC, a Delaware limited liability company; A-B Merger Sub I Inc., a Delaware corporation; A-B Merger Sub II LLC, a Delaware
limited liability company; Bowlmor AMF Corp., a Delaware corporation (the “Company”); Kingpin Intermediate Holdings
LLC, a Delaware limited liability company; and Cerberus Series Four Holdings, LLC, solely in its capacity as Stockholder Representative,
dated as of June 6, 2017, Thomas Shannon and Brett Parker (each, an “Executive”) will be eligible to participate in
an annual cash incentive plan (the “Bonus Plan”) under which the Company will provide annual bonus opportunities to
each Executive according to the terms set forth below.

 

	Bonus
    Plan
	Bonus
    Period:	Fiscal
    Year.
	Target
    Bonus:	Percentage
    of base salary or specified target amount, as specified in the Executive’s employment agreement (the “Target Bonus”).

     

    If
    the closing occurs during the 2018 fiscal year:

     

	 	 
	(i)
	if
                                            the 2017 Target Bonus has not been paid prior to the closing, the 2017 Target Bonus will
                                            be provided to the extent such bonus is appropriately reflected in the Company’s current
                                            liabilities as of the closing, and

	 	 	 	 
	 	 
	(ii)
	the
                                            2018 Bonus will not be pro rated, provided that, if the closing occurs 45 days or more after
                                            the start of the Company’s 2018 fiscal year, a pro rata liability with respect to the
                                            Executive’s 2018 bonus is appropriately reflected in the Company’s current liabilities
                                            as of the closing.

	Bonus
    Metrics:	Unless
    otherwise specified by a majority of the board of directors of the Company (the “Board”) in consultation with
    the Chief Executive Officer of the Company (the “CEO”) prior to the commencement of any Bonus Period, the performance
    metrics used to determine the payout of each bonus for a Bonus Period will be based on achievement of the budgeted EBITDA1
    set by the Board in consultation with the CEO for the applicable Bonus Period, as follows:

 

 

 

		1	EBITDA
                                            to be defined as defined in the Company’s credit agreement.

 

    1

     

    

 

		 	 	 	 
	 	Actual
    EBITDA

    as a % of Budgeted EBITDA	Bonus
    Amount

    as a % of Target Bonus	 
	 	Less
    than 85%	0%	 
	 	85%	25%	 
	 	90%	80%	 
	 	100%	100%	 
	 	125%
    or more	200%	 
	 	 	 	 
	 	Bonus
    payouts for achievement of EBITDA above 90% of Budgeted EBITDA and between the target percentages above will be calculated based
    on a sliding scale determined by linear interpolation between the lower payout percentage and the next higher payout percentage,
    whereas achievement of EBITDA between 85% and 90% of Budgeted EBITDA will result in a bonus of 25% of Target Bonus.

	Payment
    of Bonus:	Lump-sum
    cash payment based on the Company’s audited financial statements to be made promptly following the completion of the Company’s
    financial audit for the Bonus Period in which the bonus is earned, but in no event later than December 31 of the calendar year in
    which the corresponding Bonus Period ends. The Executive must continue in the service of the Company or its subsidiaries as of the
    scheduled payment date except as otherwise specified in the Executive’s employment agreement.

	Effect
    of a Termination of Employment:

     
	Unless
    otherwise specified in a written employment agreement, in the event of a termination by the Company without Cause or due to death
    or disability or by the Executive for Good Reason prior to end of applicable Bonus Period, an Executive will receive a pro rata portion
    of the Executive’s Target Bonus for the relevant Bonus Period based on actual performance for that Bonus Period.

     

    If
    the Executive’s employment is terminated by the Company without Cause or due to death or disability or by the Executive for
    Good Reason during the period between the end of the Bonus Period and the bonus payment date, the Executive will receive full payment
    of the bonus at the same time the Company pays bonuses to active employees.

     

    If
    the Executive is terminated for Cause or resigns without Good Reason during the period between the beginning of the Bonus Period
    and the bonus payment date, the Executive will forfeit the bonus.

	Clawback:	Each
    bonus will be subject to clawback to the extent that the audited financial statements for the period on which the bonus requires
    a downward adjustment to EBITDA. For the period that the Executive remains employed by the Company, any such clawback amounts may
    be repaid through a reduction of base salary or other amounts otherwise payable to the Executive, provided the Company and
    the Executive enter into a written mutual agreement providing for the terms and conditions of such repayment, including the Executive’s
    requirement to make full payment promptly and directly in the event of a termination of employment.

	Administration:	Prior
    to the commencement of any Bonus Period a majority of the Board may in consultation with the CEO set annual performance criteria.
    The Board will administer the Bonus Plan, set annual performance criteria and determine performance, all in good faith. Annual budgeted
    EBITDA shall be determined by the Board in good faith in consultation with the CEO and CFO.

 

    2

     

    

 

EXHIBIT
C

 

Form
of Mutual Release

 

1.
Release by the Executive. Thomas F. Shannon (the “Executive”), on his own behalf and on behalf of his descendants,
dependents, heirs, executors, administrators, assigns and successors, and each of them, hereby acknowledges full and complete satisfaction
of and releases and discharges and covenants not to sue Bowlmor AMF Corp. (the “Company”), its divisions, subsidiaries,
parents, or affiliated corporations, past and present, and each of them, as well as its and their assignees, successors, directors, officers,
stockholders, partners, representatives, attorneys, agents or employees, past or present, or any of them (individually and collectively,
“Releasees”), from and with respect to any and all claims, agreements, obligations, demands and causes of action,
known or unknown, suspected or unsuspected, arising out of or in any way connected with the Executive’s employment or any other
relationship with or interest in the Company, and each of them, or the termination thereof, including without limiting the generality
of the foregoing, any claim for severance pay, profit sharing, bonus or similar benefit, pension, retirement, life insurance, health
or medical insurance or any other fringe benefit, or disability, or any other claims, agreements, obligations, demands and causes of
action, known or unknown, suspected or unsuspected resulting from any act or omission by or on the part of Releasees committed or omitted
prior to the date of this General Release Agreement (this “Agreement”) set forth below, including, without limiting
the generality of the foregoing, any claim under Title VII of the Civil Rights Act of 1964, the Americans with Disabilities Act, the
Family and Medical Leave Act, or any other federal, state or local law, regulation or ordinance (collectively, the “Claims”);
provided, however, that the Executive does not waive or release Claims with respect to any of the following: (1) Claims arising from
any breach by the Company of this Agreement or Executive’s right to enforce this Agreement; (2) Claims arising with respect to
those provisions of the Employment Agreement dated as of June 6, 2017 by and between the Company and the Executive (the “Employment
Agreement”) that are intended to survive the termination of Executive’s employment with the Company, including without
limitation, Sections 5 and 19 thereof; (3) any equity-based awards previously granted by the Company to the Executive, to the extent
that such awards continue after the termination of the Executive’s employment with the Company in accordance with the applicable
terms of such awards; (4) any vested right Executive may have under any employee benefit plan, including, without limitation, any incentive
or bonus plan or policy of the Company; (5) any right to indemnification (including the advancement of legal fees) that the Executive
may have pursuant to the Employment Agreement, the bylaws or corporate charter of the Company, or under any written indemnification agreement
with the Company (or any corresponding provision of any parent, subsidiary or affiliate of the Company) with respect to any loss, damages
or expenses (including but not limited to attorneys’ fees to the extent otherwise provided) that the Executive may incur with respect
to his service as an employee, officer or director of the Company, or any of its parents, subsidiaries or affiliates; (6) with respect
to any rights that the Executive may have to insurance coverage for such losses, damages or expenses under any Company (or parent, subsidiary
or affiliate) directors and officers liability insurance policy (in the future or previously in force); (7) any rights the Executive
may have to workers’ compensation benefits or unemployment benefits under state law, or to continued medical and dental coverage
under COBRA; (8) any rights to payment of benefits that the Executive may have under a retirement plan sponsored or maintained by the
Company that is intended to qualify under Section 401(a) of the Internal Revenue Code of 1986, as amended; or (9) any rights the Executive
may have as a stockholder of the Company (or the rights of any stockholder in which Executive has a direct or indirect beneficial interest).
In the interest of clarity, in connection with the forgoing, the Executive acknowledges and agrees that he will not provide information
to others that would support any claims against the Company or encourage or participate in any such claims. In addition, this release
does not cover any Claim that cannot be so released as a matter of applicable law. The Executive acknowledges and agrees that he has
received any and all leave and other benefits that he has been and is entitled to pursuant to the Family and Medical Leave Act of 1993.
This release does not prevent the Executive from filing a charge with or participating in an investigation by a governmental administrative
agency or cooperating as required by law with any governmental inquiry or investigation or judicial proceeding; provided, however, that
the Executive waives any right to receive any monetary award resulting from such a charge or investigation, including, without limitation,
interest, penalties, fines, and attorneys’ fees.

 

    C-1

     

    

 

2.
Release by the Company. In consideration of Executive’s release of claims as set forth above, the Company, on behalf of
itself and its parents, divisions, subsidiaries, parents, or affiliated corporations, hereby unconditionally and irrevocably releases
and forever discharge the Executive, his descendants, dependents, heirs, executors, administrators, assigns and successors, past, present
and future, from all Claims arising out of or in any way connected with the Executive’s employment or any other relationship with
or interest in the Company, and each of them, or the termination thereof; provided, however, that the foregoing release does not apply
to (1) any obligation of the Executive pursuant to this Agreement or Section 6 of the Employment Agreement, (2) any act of fraud or material
dishonesty by Executive, (3) any act or activity by the Executive that constitutes a crime under applicable law, or (4) any claims or
rights related to, or arising under, that certain Stockholders’ Agreement by and among (i) the Company, (ii) A-B Parent LLC, a
Delaware limited liability company, (iii) Cobalt Recreation LLC, a Delaware limited liability company, (iv) the Executive and (v) Atairos
Group, Inc., a Cayman Islands exempted company, dated as of June 6, 2017 or that certain Support Agreement attached as Exhibit A to the
Merger Agreement.

 

3.
Release of Unknown Claims. It is the intention of each of the parties hereto in executing this Agreement that the same shall be
effective as a bar to each and every claim, demand and cause of action hereinabove specified. In furtherance of this intention, each
such party hereby expressly waives any and all rights and benefits conferred upon him or it by any law, statute, or legal doctrine that
would otherwise prevent the release of unknown claims and expressly consents that this Agreement shall be given full force and effect
according to each and all of its express terms and provisions, including those related to unknown and unsuspected claims, demands and
causes of action, if any, as well as those relating to any other claims, demands and causes of action hereinabove specified. Each such
party acknowledges that he or it may hereafter discover claims or facts in addition to or different from those which such party now knows
or believes to exist with respect to the subject matter of this Agreement and which, if known or suspected at the time of executing this
Agreement, may have materially affected this settlement. Nevertheless, each such party hereby waives any right, claim or cause of action
that might arise as a result of such different or additional claims or facts. Each such party acknowledges that he or it understands
the significance and consequence of such release and waiver.

 

    C-2

     

    

 

4.
ADEA Waiver. The Executive expressly acknowledges and agrees that by entering into this Agreement, he is waiving any and all rights
or claims that he may have arising under the Age Discrimination in Employment Act of 1967, as amended (“ADEA”), which
have arisen on or before the date of execution of this Agreement. The Executive further expressly acknowledges and agrees that:

 

(a)
In return for this Agreement, he will receive consideration beyond that which he was already entitled to receive before entering into
this Agreement;

 

(b)
He is hereby advised in writing by this Agreement to consult with an attorney before signing this Agreement;

 

(c)
He was given a copy of this Agreement on [                    ]
and informed that he had [twenty-one (21)/forty-five (45) days] within which to consider this Agreement and that if he wished to
execute this Agreement prior to expiration of such [21/45]-day period, he should execute the Acknowledgement and Waiver attached hereto
as Exhibit C-1;

 

(d)
Nothing in this Agreement prevents or precludes the Executive from challenging or seeking a determination in good faith of the validity
of this waiver under the ADEA, nor does it impose any condition precedent, penalties or costs from doing so, unless specifically authorized
by federal law; and

 

(e)
He was informed that he has seven (7) days following the date of execution of this Agreement in which to revoke this Agreement, and this
Agreement will become null and void if the Executive elects revocation during that time. Any revocation must be in writing and delivered
in accordance with the notice provisions of the Employment Agreement, and must be received by the Company during the seven-day revocation
period. In the event that the Executive exercises his right of revocation, neither the Company nor the Executive will have any obligations
under this Agreement.

 

5.
No Transferred Claims. The Executive represents and warrants to the Company that he has not heretofore assigned or transferred
to any person not a party to this Agreement any released matter or any part or portion thereof.

 

6.
Non-Disparagement. For three (3) years following the termination of the Executive’s employment, (i) the Executive will not
disparage or defame the Company or any of its directors or officers in any medium to any person, and (ii) the Company and its officers
and directors will not disparage or defame the Executive in any medium to any person; provided, however, that the foregoing
shall not prohibit any party from (A) giving truthful testimony in any legal proceeding pending before any agency or court of the United
States or state government or in any arbitration proceeding relating to this Agreement or otherwise required by law or any administrative
or legislative body or (B) responding to incorrect, disparaging or derogatory public statements to the extent necessary to correct or
refute such public statements.

 

7.
Waiver of Reemployment or Reinstatement. The Executive waives reemployment or reinstatement and agrees not to apply for employment
or otherwise seek to be hired, rehired, employed, reemployed, or reinstated by any Releasee. The Executive agrees that the Releasees
have no obligation, contractual or otherwise, to reemploy or reinstate him in the future.

 

    C-3

     

    

 

8.
Miscellaneous. The following provisions shall apply for purposes of this Agreement:

 

(a)
Successors. This Agreement is personal to the Executive and shall not be assignable by the Executive. This Agreement shall inure
to the benefit of and be binding upon the Company, the Releasees, and their respective successors and assigns.

 

(b)
Number and Gender. Where the context requires, the singular shall include the plural, the plural shall include the singular, and
any gender shall include all other genders.

 

(c)
Section Headings. The section headings of, and titles of paragraphs and subparagraphs contained in, this Agreement are for the
purpose of convenience only, and they neither form a part of this Agreement nor are they to be used in the construction or interpretation
thereof.

 

(d)
Governing Law. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK, WITHOUT
GIVING EFFECT TO ANY CHOICE OF LAW OR CONFLICTING PROVISION OR RULE (WHETHER OF THE STATE OF NEW YORK OR ANY OTHER JURISDICTION) THAT
WOULD CAUSE THE LAWS OF ANY JURISDICTION OTHER THAN THE STATE OF NEW YORK TO BE APPLIED. IN FURTHERANCE OF THE FOREGOING, THE INTERNAL
LAW OF THE STATE OF NEW YORK WILL CONTROL THE INTERPRETATION AND CONSTRUCTION OF THIS AGREEMENT, EVEN IF UNDER SUCH JURISDICTION’S
CHOICE OF LAW OR CONFLICT OF LAW ANALYSIS, THE SUBSTANTIVE LAW OF SOME OTHER JURISDICTION WOULD ORDINARILY APPLY.

 

(e)
Severability. It is the desire and intent of the parties hereto that the provisions of this Agreement be enforced to the fullest
extent permissible under the laws and public policies applied in each jurisdiction in which enforcement is sought. Accordingly, if any
particular provision of this Agreement shall be adjudicated by a court of competent jurisdiction to be invalid, prohibited or unenforceable
under any present or future law, and if the rights and obligations of any party under this Agreement will not be materially and adversely
affected thereby, such provision, as to such jurisdiction, shall be ineffective, without invalidating the remaining provisions of this
Agreement or affecting the validity or enforceability of such provision in any other jurisdiction, and to this end the provisions of
this Agreement are declared to be severable; furthermore, in lieu of such invalid or unenforceable provision there will be added automatically
as a part of this Agreement, a legal, valid and enforceable provision as similar in terms to such invalid or unenforceable provision
as may be possible. Notwithstanding the foregoing, if such provision could be more narrowly drawn (as to geographic scope, period of
duration or otherwise) so as not to be invalid, prohibited or unenforceable in such jurisdiction, it shall, as to such jurisdiction,
be so narrowly drawn, without invalidating the remaining provisions of this Agreement or affecting the validity or enforceability of
such provision in any other jurisdiction.

 

    C-4

     

    

 

(f)
Modifications. This Agreement may not be amended, modified or changed (in whole or in part), except by a formal, definitive written
agreement expressly referring to this Agreement, which agreement is executed by both of the parties hereto.

 

(g)
Waiver. Neither the failure nor any delay on the part of a party to exercise any right, remedy, power or privilege under this
Agreement shall operate as a waiver thereof, nor shall any single or partial exercise of any right, remedy, power or privilege preclude
any other or further exercise of the same or of any right, remedy, power or privilege, nor shall any waiver of any right, remedy, power
or privilege with respect to any occurrence be construed as a waiver of such right, remedy, power or privilege with respect to any other
occurrence. No waiver shall be effective unless it is in writing and is signed by the party asserted to have granted such waiver.

 

(h)
Arbitration; Waiver of Jury Trial. The Executive and the Company agree that any controversy or claim arising out of or relating
to this Agreement, its enforcement or interpretation, or because of an alleged breach, default, or misrepresentation in connection with
any of its provisions, or any other controversy or claim arising out of Executive’s employment, including, but not limited to,
any state or federal statutory claims, shall be submitted to arbitration in accordance with the arbitration and dispute resolution provisions
set forth in the Employment Agreement). WITHOUT LIMITING THE PRECEDING SENTENCE, EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES
ALL RIGHT TO TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM ARISING OUT OF OR RELATING TO THIS AGREEMENT.

 

(i)
Additional Actions. The Executive agrees to cooperate fully and to execute any and all supplementary documents and to take all
additional reasonable actions that may be necessary or appropriate to give full force to the basic terms and intent of this Agreement
and that are not inconsistent with its terms.

 

(j)
Counterparts. This Agreement may be executed in any number of counterparts, each of which shall be deemed an original as against
any party whose signature appears thereon, and all of which together shall constitute one and the same instrument. This Agreement shall
become binding when one or more counterparts hereof, individually or taken together, shall bear the signatures of all of the parties
reflected hereon as the signatories. Photographic copies of such signed counterparts may be used in lieu of the originals for any purpose.

 

(k)
Legal Counsel; Mutual Drafting. Each party recognizes that this is a legally binding contract and acknowledges and agrees that
such party has had the opportunity to consult with legal counsel of such party’s choice. Each party has cooperated in the drafting,
negotiation and preparation of this Agreement. Hence, in any construction to be made of this Agreement, the same shall not be construed
against either party on the basis of that party being the drafter of such language. The Executive agrees and acknowledges that the Executive
has read and understands this Agreement, is entering into it freely and voluntarily without coercion, and has been advised to seek counsel
prior to entering into this Agreement and has had ample opportunity to do so.

 

    C-5

     

    

 

The
undersigned have read and understand the consequences of this Agreement and voluntarily sign it. The undersigned declare under penalty
of perjury under the laws of the State of New York that the foregoing is true and correct.

 

EXECUTED
this ___________ day of ___________ 20____, at _______________County, ___________.

 

 

	 	“EXECUTIVE”
	 	 
	 	 
	 	Thomas F. Shannon

 

 

EXECUTED
this ___________ day of ___________ 20____, at _______________County, ___________.

 

 

	 	“COMPANY”
	 	 
	 	BOWLMOR AMF CORP.
	 	 
	 	By:	 
	 	Name:	 
	 	Title:	 

 

    C-6

     

    

 

EXHIBIT
C-1

 

ACKNOWLEDGMENT
AND WAIVER

 

I,
Thomas F. Shannon, hereby acknowledge that I was given [21/45] days to consider the foregoing General Release Agreement and voluntarily
chose to sign the General Release Agreement prior to the expiration of the [21/45]-day period.

 

I
declare under penalty of perjury under the laws of the State of New York that the foregoing is true and correct.

 

EXECUTED
this ___________ day of ___________ 20____, at _______________County, ___________.
 

 

	 	 
	 	Thomas F. Shannon

 

    C-7

     

    

 

EXHIBIT
D

 

Prior
Inventions

 

1.
Except as listed in Section 2 below, the following is a complete list of all inventions, original works of authorship, developments,
improvements and trade secrets which relate to the Company’s or any Subsidiary’s actual or proposed business, products or
research and development that were made, conceived or first reduced to practice by me prior to my employment with the Company:

 

	 	☐	No inventions or improvements
	 	 	 
	 	☐	See below (please provide identifying number, if applicable, and a short
  description):
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 		 
	 	☐	Additional Sheets Attached

 

 

2.
Due to a prior confidentiality agreement, I cannot provide a full disclosure under Section 1 above with respect to inventions or improvements
generally listed below, the proprietary rights and duty of confidentiality with respect to which I owe to the following party(ies):

 

	 	Invention or Improvement	 	Party(ies)	 	Relationship
	 	 	 	 	 	 
	1.	 	 	 	 	 
	 	 	 	 	 	 
	2.	 	 	 	 	 
	 	 	 	 	 	 
	3.	 	 	 	 	 

 

		☐	Additional
                                            Sheets Attached

 

    D-1

     

    

 

EXHIBIT
E

 

Equity
Incentive Plan Term Sheet

(attached)

 

    E-1

     

    

 

Term
Sheet

 

Bowlmor
AMF Corp. Stock Option Plan

 

In
connection with the transactions contemplated by the Agreement and Plan of Merger (the “Merger Agreement”) by and
among A-B Parent LLC, a Delaware limited liability company; A-B Merger Sub I Inc., a Delaware corporation; A-B Merger Sub II LLC, a Delaware
limited liability company; Bowlmor AMF Corp., a Delaware corporation (the “Company”); Kingpin Intermediate Holdings
LLC, a Delaware limited liability company; and Cerberus Series Four Holdings, LLC, solely in its capacity as Stockholder Representative,
dated as of June 6, 2017, the executives of the Company (each, an “Executive”) will be eligible to participate in
an equity incentive plan (the “Option Plan”) under which the Company will grant options to purchase shares of the
Company’s common stock and such other equity and equity-based compensation awards as the Board may grant in consultation with the
CEO. The options to be issued under the Option Plan will be subject to the terms set forth in a plan document and in individual award
agreements to be adopted and entered into after the closing of the transactions contemplated by the Merger Agreement (the “Closing”),
and all stock acquired through the exercise of the options will be subject to the Stockholders’ Agreement by and among (i) the
Company, (ii) A-B Parent LLC, a Delaware limited liability company, (iii) Cobalt Recreation LLC, a Delaware limited liability company,
(iv) Thomas F. Shannon and (v) Atairos Group, Inc., a Cayman Islands exempted company, dated as of June 6, 2017 (the “Stockholders’
Agreement”), and such other documents that are reasonably required.

 

The
following sets forth the currently contemplated principal terms of the Option Plan. It is understood that the terms outlined below are
preliminary, nonbinding and subject to change and will be qualified in their entirety by the applicable plan document, any individual
award agreements and the Stockholders’ Agreement. However, certain key terms of the awards, such as vesting, percentage of the
plan pool and post-termination exercise period, for the CEO and CFO shall be incorporated into the applicable employment agreement.

 

	Options
	Issuer:	The
    Company
	Awards:	Options
                                            (“Options”) to purchase shares of the Company’s common stock (“Shares”)
                                            and such other equity and equity-based compensation awards as the Board may grant in consultation
                                            with the CEO.

	Plan
    Pool:	10%
                                            of the fully diluted common stock of the Company after Closing (the “Pool”),
                                            to be allocated as indicated below.

	Allocation:	 	●

	Options
                                            on 70% of the Pool (the “Initial Options”) will be granted to Executives
                                            as of the date of the Closing (the “Closing Date”), as determined by the
                                            Board in consultation with the CEO; provided that 75% of the Initial Options shall be allocated
                                            to the CEO and CFO (with a 75%/25% split between the CEO and CFO). 

	 	 	 	 
	 	 	●	Options
    on the remaining 30% of the Pool (the “Future Options”) will be reserved for future grants to Executives as determined
    by the Board in consultation with the CEO.

 

    1

     

    

 

	Exercise
    Price:	The
                                            exercise price of the Initial Options will be equal to the fair market value of the underlying
                                            Shares immediately following the Closing, as derived from the transaction value.

     

    The
    per Share exercise price of the Future Options shall be the fair market value of the underlying Shares as of the date that such Future
    Options are granted, unless otherwise determined by the Board in consultation with the CEO.

	Vesting:

                                                                                 
	75%
                                            of each Initial Option (the “Service Segment”) will vest and become exercisable
                                            in quarterly installments over a 4 year period, subject to the Executive’s continued
                                            service with the Company or its subsidiaries as of each such vesting date, provided that
                                            any unvested portion of the Service Segment will become fully vested upon a Sale of the Company
                                            (as defined below) or Triggering IPO (as defined below), subject to the Executive’s
                                            continued service with the Company or its subsidiaries as of the date of the Sale of the
                                            Company or Triggering IPO.

     

    25%
    of each Initial Option (the “Performance Segment”) will (A) vest in four equal annual installments with 25% vesting
    on each of the first four anniversaries of the grant date, subject to the Executive’s continued service with the Company or
    its subsidiaries as of each such anniversary and (B) become exercisable, as of or following vesting, in full, in connection with
    any Sale of the Company or Triggering IPO, provided that the Triggering IPO or Sale of Company results in an Atairos Return that
    is equal to a multiple of at least 2.0 times the Atairos Investors’ aggregate invested capital in the Company on the date of
    grant, where

     

	 	 	●	“Atairos
    Investors” means Atairos and its affiliates and permitted transferees.
	 	 	 	 
	 	 	●	“Atairos
    Return” means, as of any Sale of the Company or Triggering IPO, the sum of (x) the value of all proceeds that will actually
    be received by the Atairos Investors as a result of the divestiture of the Atairos Investors’ interest, direct or indirect,
    in the Company in connection with the relevant Sale of the Company or Triggering IPO, valued as of the date received by the Atairos
    Investors and net of any customary transaction expenses incurred by the Atairos Investors associated with such divestiture (to the
    extent such expenses are not borne by the Company), (y) the value of all prior proceeds actually received by the Atairos Investors
    from all previous divestitures of the Atairos Investors’ interest, direct or indirect, in the Company and any cash dividends
    or distributions received by the Atairos Investors as the result of any extraordinary recapitalization transactions by the Company,
    in each case valued at the fair value of such proceeds, dividends or distributions as of the date received by the Atairos Investors
    and net of any customary transaction expenses associated with such divestitures, dividends or distributions incurred by the Atairos
    Investors (to the extent such expenses are not borne by the Company) and (z) the value of the Atairos Investors’ interest,
    direct or indirect, in the Company that will be retained by the Atairos Investors following the relevant Sale of the Company or Triggering
    IPO, valued by reference to the fair value of the proceeds received by the Atairos Investors in connection with the Sale of the Company
    or Triggering IPO and net of any customary transaction expenses associated with such divestitures incurred by the Atairos Investors
    (to the extent such expenses are not borne by the Company).

 

    2

     

    

 

	 	 	●	“Atairos
    Cumulative Interest” means the greatest amount of the Atairos Investors’ collective interest, direct or indirect,
    in the Company acquired at any time prior to a Sale of the Company or Triggering IPO, as the case may be.
	 	 	 	 
	 	 	●	“Triggering
    IPO” means an underwritten public offering of Shares pursuant to an effective registration statement under the Securities
    Act of 1933 (as amended), other than pursuant to a registration statement on Form S-4 or Form S-8 or any similar or successor form,
    in which the Atairos Investors are secondary sellers and after which the Atairos Investors will have divested 15% or more of the
    Atairos Cumulative Interest.
	 	 	 	 
	 	 	●	“Sale
    of the Company” means (i) a negotiated sale of interests in the Company pursuant to a stock sale, exchange or similar transaction
    (other than a Triggering IPO) or a merger of the Company into another company, provided any such transaction results in the Atairos
    Investors having divested 50% or more of the Atairos Cumulative Interest to one or more parties all of whom are not affiliates of
    any of the Atairos Investors, Tom Shannon or the Company (collectively, “Initial Investors”), (ii) a sale of all
    or substantially all of the assets of the business conducted by the Company and its subsidiaries to one or more parties, other than
    parties that the Initial Investors control or in which the Initial Investors own a majority interest.
	 	

                                                                                 

                                                                                The
                                            Future Options will vest pursuant to the schedule and terms determined by the Board in consultation
                                            with the CEO at the time of grant.

	Term:	The
    Initial Options will expire on the 12th anniversary of the grant date, subject to earlier expiration upon a termination of employment
    or service (as described below).

     

    The
    Future Options will bear a term determined by the Board in consultation with the CEO at the time of grant.

	Termination
    of Employment or Service / Call Right:

     

     
	If
                                            employment is terminated by the Company without Cause or due to death or disability or, in
                                            the case of the CEO and CFO, by the Executive for Good Reason in accordance with terms of
                                            an employment agreement:

                                                                                 

	 

                                                                            
	●

                                                                            
	An
                                            Executive will be vested in any portion of an Initial Option that has previously vested;

                                                                                                             

	 	●	In
    addition, the Executive will vest in the next 25% of the Service Segment and will be deemed to have satisfied service requirement
    with respect to next 25% of the Performance Segment, which will remain eligible to become exercisable if a Sale of the Company or
    Triggering IPO occurs within 18 months of termination;

 

    3

     

    

 

	 	 	●	Any
    remaining unvested portion of the Initial Option will be forfeited; and
	 	 	 
	 	●	The
    Executive will have 90 days1 after termination to exercise the vested portion of the Initial Option.
	 	 	 
	If
    employment is terminated by the Company for Cause:
	 	 	 
	 	●	All
    vested and unvested Initial Options will be forfeited.
	 	 	 
	If
    employment is terminated by the Executive without Good Reason:
	 	 	 
	 	●	An
    Executive will be vested in any portion of an Initial Option that has previously vested;
	 	 	 
	 	●	The
    unvested portion of the Option will be forfeited; and
	 	 	 
	 	●	The
    Executive will have 90 days after termination to exercise the vested portion of the Initial Option.
	 	 	 
	The
                                            terms above may be varied for any Future Option, as determined by the Board in consultation
                                            with the CEO at the time of grant.

 

Upon
any termination of employment, any Shares an Executive receives or has received upon the exercise of any Options will be subject to the
Stockholders’ Agreement, including any Company call rights provided therein.

	Option
    Adjustment/Net Exercise:	All
                                            options will have standard adjustment provisions requiring equitable adjustment to reflect
                                            certain corporate transactions.

 

The
Options will include net exercise provisions allowing for exercise net of exercise price and taxes; provided that:

	 	 	 
	 	●	for
    Executives other than the CEO and CFO, such net exercise will not be available after the Option holder’s termination of employment
    by the Company for Cause or a resignation by the Option holder, and
	 	 	 
	 	 	●	for
    the CEO and CFO, such net exercise will not be available after the Option holder’s termination of employment by the Company
    for Cause (such Options will be forfeited).

 

 

 

		1	The
                                            CEO and CFO shall have 1 year to exercise Service Segment options and 18 months to exercise
                                            Performance Segment options, subject to the Company’s right to call the common stock
                                            issued upon exercise of Options under the Stockholders Agreement.

 

    4

     

    

 

	Restrictive
    Covenants:	In
                                            consideration for the grant of the Options, each Executive will be required to enter into
                                            a restrictive covenant agreement providing for (i) confidentiality and intellectual property
                                            covenants, and (ii) noncompetition and nonsolicitation of employees and customers covenants
                                            with a duration equal to the greater of (x) the duration described in any applicable employment
                                            agreement or (y) the term of the Executive’s service and two (2) years following termination
                                            of such service; provided that no restrictive covenant agreement shall provide for restrictive
                                            covenants inconsistent with the covenants provided in the Executive’s employment agreement.

                                                                                 

                                                                                Options
                                            will be subject to forfeiture in the event of an uncured material breach of applicable restrictive
                                            covenants, which, for the CEO and CFO, shall be a breach that is defined as a “Restrictive
                                            Covenant Breach” in the Stockholders’ Agreement.

	Stockholders’
    Agreement:	As
    condition to exercise, Executives will agree to execute an agreement to be bound by the Stockholders’ Agreement, which shall
    include customary terms relating to the Options and Shares underlying the Options, including customary transfer restrictions, drag
    and tag rights and Company call rights upon the termination of an Option holder’s service with the Company.
	Governing
    Law:	Delaware.
	Definitions:

                                                                                 
	“Cause”
                                            will have the meaning set forth in an Executive’s employment agreement or, in the absence
                                            of such a definition, shall mean:

                                                               

	 	 	(i)	conviction
    of a felony or any crime involving dishonesty or theft;
	 	 	 
	 	 	(ii)	fraudulent,
    unlawful or grossly negligent conduct in connection with the Executive’s employment duties or responsibilities;
	 	 	 
	 	 	(iii)	willful
    misconduct;
	 	 	 
	 	 	(iv)	contravention
    of specific lawful directions from the Board related to a material duty or responsibility;
	 	 	 
	 	 	(v)	material
    breach of the obligations of any agreement with the Company;
	 	 	 
	 	 	(vi)	acts
    of dishonesty resulting or intending to result in personal gain or enrichment at the expense of the Company or its affiliates;
	 	 	 
	 	 	(vii)	material
    failure to comply with a material written policy of the Company; or
	 	 	 
	 	 	(viii)	material
    act or omission which is, or could reasonably be expected to become, materially injurious to the reputation or business of the Company
    or its affiliates.

 

    5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00331-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00331-of-00352.parquet"}]]